Endothelial Biology and the Bone Marrow (Englisch)
- Neue Suche nach: Cuddihy, A. R.
- Neue Suche nach: Crooks, G. M.
- Neue Suche nach: Cuddihy, A. R.
- Neue Suche nach: Crooks, G. M.
In:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
;
13
;
43-46
;
2007
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Endothelial Biology and the Bone Marrow
-
Beteiligte:Cuddihy, A. R. ( Autor:in ) / Crooks, G. M. ( Autor:in )
-
Erschienen in:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION ; 13 ; 43-46
-
Verlag:
- Neue Suche nach: Elsevier Science B. V. Amsterdam
-
Erscheinungsdatum:01.01.2007
-
Format / Umfang:4 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 617.4
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 617.4 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 13
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
3:WT1-specific T lymphocytes participate in the elimination of acute lymphoblastic leukemia following allogeneic stem cell transplantationRezvani, K. / Yong, A. S. / Price, D. A. / Mielke, S. / Savani, B. / Gostick, E. / Douek, D. / Barrett, A. J. et al. | 2007
- 1
-
The 2007 Educational Supplement on Hemopoetic Cell TransplantationHeslop, H. et al. | 2007
- 1
-
1:Cytotoxic T lymphocyte therapy for the treatment and prevention of adenovirus infection after stem cell transplantBollard, C. M. / Myers, G. D. / Weiss, H. / Gee, A. P. / Leung, K. / Krance, R. A. / Brenner, M. K. / Rooney, C. M. / Heslop, H. E. / Leen, A. M. et al. | 2007
- 1
-
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based ReviewOliansky, D. M. / Rizzo, J. D. / Aplan, P. D. / Arceci, R. J. / Leone, L. / Ravindranath, Y. / Sanders, J. E. / Smith, F. O. / Wilmot, F. / McCarthy, P. L. et al. | 2007
- 1
-
2:A distinct pattern of Non-HLA polymorphisms predicts an increased risk for GvHD without benefit of GvL in HLA matched sibling transplants for chronic myeloid leukemia (CML)Dickinson, A. M. / Pearce, K. F. / Norden, J. / Neylor, A. / Holler, E. / Rocha, V. / Gluckman, E. / Kolb, H. J. / Hromadnikova, I. / Sedlacek, P. et al. | 2007
- 2
-
Transplantation’s Greatest Challenges: Advances in Chronic Graft-versus-Host DiseaseShlomchik, W. D. / Lee, S. J. / Couriel, D. / Pavletic, S. Z. et al. | 2007
- 3
-
4:Effects of minor histocompatibility antigen mismatching on clinical outcome in HLA-matched, unrelated stem cell transplantsWarden, M. B. / Haagenson, M. / Wang, T. / Pietz, B. C. / Goulmy, E. / Warren, E. H. / Spellman, S. / Ellis, T. M. et al. | 2007
- 3
-
5:Changes in TNFR1 ratios in the first week post-myeloablative allogeneic BMT correlate with GVHD, TRM and OS in childrenKitko, C. / Paczesny, S. / Yanik, G. / Braun, T. / Jones, D. / Whitfield, J. / Choi, S. / Hutchinson, R. / Ferrara, J. / Levine, J. E. et al. | 2007
- 4
-
6:Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloablative HLA matched related and unrelated bone marrow transplantation (BMT)Luznik, L. / Fuchs, E. J. / Chen, A. R. / Kaup, M. / Bright, E. C. / Bolanos-Meade, J. / Hess, A. D. / Jones, R. J. et al. | 2007
- 5
-
8:High recipient CD4+CD25hi regulatory T-cell level pre-transplant is associated with reduced overall survival after unrelated donor hematopoyetic stem cell transplantationPrieto-Hinojosa, A. / Madrigal, J. A. / Shaw, B. E. / Mayor, N. P. / Marsh, S. G. / Travers, P. / Duarte, R. F. et al. | 2007
- 5
-
9:Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders: A report from the center for international blood and marrow transplant research (CIBMTR)Gupta, V. / Tomblyn, M. / Pederson, T. / Thompson, J. / Gress, R. / Storek, J. / Burik, J. A. / van Horowitz, M. / Keating, A. et al. | 2007
- 5
-
7:Long-term outcome of methotrexate-free GVHD prophylaxis using sirolimus and tacrolimus in matched related (MRD) and unrelated donor (URD) peripheral blood stem cell transplantation (PBSCT)Cutler, C. / Li, S. / Ho, V. / Koreth, J. / Alyea, E. / Soiffer, R. J. / Antin, J. H. et al. | 2007
- 6
-
11:Impact of pre-transplant splenectomy on patients with β thalassemia major undergoing a matched related allogeneic stem cell transplantationMathews, V. / George, B. / Viswabandya, A. / Lakshmi, K. M. / Chandy, M. / Srivastava, A. et al. | 2007
- 6
-
10:A new stratification strategy that identifies a high risk subset of class III patients among children with β thalassemia major undergoing a matched related allogeneic stem cell transplantationMathews, V. / George, B. / Lakshmi, K. M. / Viswabandya, A. / Chandy, M. / Srivastava, A. et al. | 2007
- 6
-
12:Early hematopoietic chimerism predicts engraftment after umbilical cord blood stem cell transplantationMoscardó / F. / Senent, L. / Sanz, J. / Planelles, D. / Lorenzo, I. / Cervera, J. / Jimé / nez, C. / Montesinos, P. et al. | 2007
- 7
-
13:Unrelated cord blood transplantation (UCBT) for 59 pediatric patients with benign indications using plasma depleted cord blood (PD CB) – an audited retrospective analysisRosenthal, J. / Jaing, T. H. / Chan, L. L. / Eames, G. / Graham, M. / Tan, A. M. / Lin, H. P. / Nademanee, A. / Karanes, C. / Wang, B. et al. | 2007
- 7
-
14:Estimation of high-resolution HLA-a*, -B*, -c*, -DRB1* haplotypes and implications for stem cell donor registry planningSchmidt, A. H. / Baier, D. / Stahr, A. / Rutt, C. et al. | 2007
- 8
-
15:AMD3100 plus G-CSF mobilizes the majority of non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), and Hodgkin’s disease (HD) patients who failed prior mobilization with other regimensCalandra, G. / McCarty, J. / McGuirk, J. / Barlogie, B. / Crocker, S. A. / Badel, K. et al. | 2007
- 8
-
16:Kinetics of autologous stem cell mobilization failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and chemotherapy/G-CSF on remobilization successDiPersio, J. F. / Smith, A. / Sempek, D. / Baker, A. / Jiang, S. / Vij, P. / Cashen, A. / Westervelt, P. et al. | 2007
- 9
-
17:Impact of disease and mobilizing agents on initial and remobilization failureDiPersio, J. F. / Smith, A. / Sempek, D. / Baker, A. / Jiang, S. / Vij, P. / Cashen, A. / Westervelt, P. et al. | 2007
- 9
-
18:Autologous peripheral blood stem cell transplant using busulfan, etoposide, high dose Ara-C, and G-CSF priming as conditioning regimen in patients with acute myeloid leukemia in first complete remissionMoscardó / F. / Dı / az Mediavilla, J. / de la Rubia, J. / Ferná / ndez, P. / Rayó / n, C. / Cañ et al. | 2007
- 9
-
19:Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myelomaQazilbash, M. H. / Jindani, S. / Gul, Z. / Saliba, R. / Hosing, C. / Mendoza, F. / Qureshi, S. P. / Weber, D. M. / Wang, M. / Flosser, T. et al. | 2007
- 10
-
20:Autologous stem cell transplantation for elderly patients with multiple myelomaQazilbash, M. H. / Gul, Z. / Jindani, S. / Saliba, R. / Hosing, C. / Mendoza, F. / Qureshi, S. P. / Weber, D. M. / Wang, M. / Flosser, T. et al. | 2007
- 10
-
22:Ex-vivo expansion (EvE) of previously cryopreserved cord blood (CB) into natural killer (NK) cells with enhanced AML and neuroblastoma cytotoxicity: Potential role of CB NK cells in adoptive cellular immunotherapy (ACI)Ayello, J. / Satwani, P. / van de Ven, C. / Shereck, E. / Roman, E. / Wapner, R. J. / Cairo, M. S. et al. | 2007
- 10
-
21:Total marrow irradiation (TMI) using helical tomotherapy: Dosimetric analysis demonstrates reduced organ doses which correlate with reduction in acute toxicities and predict for escalation of dose to target marrow beyond that achievable by standard TBIWong, J. Y. / Liu, A. / Schultheiss, T. / Parker, P. / Krishnan, A. / Sahebi, F. / Karanes, C. / Spielberger, R. / Rosenthal, J. / Forman, S. et al. | 2007
- 11
-
23:Early hematopoietic cells, including megakaryocyte progenitors, are recovered in ALDH bright cell populations isolated by cell sorting from previously frozen umbilical cord bloodDeibert, E. / Gentry, T. / Foster, S. J. / Kurtzberg, J. / Balber, A. E. et al. | 2007
- 11
-
25:Blood eosinophilia as a marker of favorable outcome after allogeneic stem cell transplantationAisa, Y. / Mori, T. / Nakazato, T. / Shimizu, T. / Yamazaki, R. / Ikeda, Y. / Okamoto, S. et al. | 2007
- 11
-
24:PD-1 is required to induce peripheral CD8 T cell tolerance in recipients of allogeneic bone marrow transplantation with anti-CD154Haspot, F. / Fehr, T. / Hogan, T. / Honjo, T. / Sykes, M. et al. | 2007
- 11
-
Regulatory T Cells: Historical PerspectiveChao, N. et al. | 2007
- 12
-
Promise and Challenges of Human Regulatory T Cells in the ClinicNegrin, R. S. / Hou, J. Z. et al. | 2007
- 12
-
26:A critical contribution of donor -173G/C polymorphism of macrophage migration inhibitory factor gene to the development of chronic graft versus host diseaseChang, Y. / Holler, E. / Greinix, H. T. / Dickinson, A. M. / Wolff, D. / Andreesen, R. / Hildebrandt, G. C. et al. | 2007
- 12
-
27:Treatment of experimental acute graft-versus-host disease using extracorporeal phototherapy: A novel murine modelGatza, E. / Rogers, C. E. / Clouthier, S. G. / Ferrara, J. L. et al. | 2007
- 13
-
29:Rapid expansion of acute myeloid leukemia-reactive cytotoxic T cells from CD8+CD62L+ blood lymphocytes of HLA-matched healthy donors in vitroDistler, E. / Woelfel, C. / Pesth, S. / Kaus, N. / Wehler, T. C. / Meyer, R. G. / Nonn, M. / Hartwig, U. F. / Huber, C. / Woelfel, T. et al. | 2007
- 13
-
30:An integrated genetic-protein analysis of the TNF-family pathway predicts for GVHDLevine, J. E. / Kitko, C. / Goyal, R. / Ferrell, R. / Braun, T. / Mullighan, C. / Hanauer, D. / Choi, S. / Paczesny, S. / Mineishi, S. et al. | 2007
- 13
-
28:A multicenter prospective randomized Phase II study in patients with corticosteroid-refractory/dependent/intolerant chronic cutaneous GVHD given either extracorporeal photoimmune therapy with UVADEX® in conjunction with conventional therapy or conventional therapy aloneGreinix, H. T. / Van Besien, K. / Apperley, J. / Bacigalupo, A. / Elmaagacli, A. / Grigg, A. / Kolb, H. J. / Bouzas, L. / Michallet, M. / Reddy, V. S. et al. | 2007
- 14
-
31:Tumor-activated human NK cells – potential for “off-the-shelf” immunotherapyLowdell, M. W. / North, J. / Bakhsh, I. / Marden, C. / Anderson, R. / Pittman, H. / Mackinnon, S. et al. | 2007
- 14
-
32:Single versus double umbilical cord blood transplantation (UCBT): Higher risk of acute graft-versus-host disease (GVHD) but lower transplant related mortality (TRM) in recipients of double UCBTMacMillan, M. L. / Brunstein, C. / DeFor, T. E. / Blazar, B. R. / Weisdorf, D. J. / Wagner, J. E. et al. | 2007
- 15
-
33:Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)Nadal, E. / Kaeda, J. / Apperley, J. F. / Lechler, R. / Dazzi, F. et al. | 2007
- 15
-
34:Preserved anti-viral responses and improved survival in steroid refractory GVHD using a combination of daclizumab and infliximabRao, K. / Rao, A. / Karlsson, H. / Veys, P. / Amrolia, P. et al. | 2007
- 15
-
35:Histone deacetylase inhibitors induce indoleamine 2, 3-dioxygenase and modulate dendritic cell functionsReddy, P. / Sun, Y. / Maeda, Y. / Weisiger, E. / Duran-Struuck, R. / Dinarello, C. / Ferrara, J. L. et al. | 2007
- 16
-
36:Donor-reactive thymic-dependent Th1 cells cause chronic GVHDSakoda, Y. / Hashimoto, D. / Asakura, S. / Takeuchi, K. / Harada, M. / Tanimoto, M. / Teshima, T. et al. | 2007
- 16
-
38:Prediction of acute graft versus host disease after allogeneic hematopoietic stem cell transplantation by a proteomic aGvHD-specific patternWeissinger, E. M. / Schiffer, E. / Hertenstein, B. / Ferrara, J. L. / Holler, E. / Stadler, M. / Kolb, H. J. / Zander, A. / Zuerbig, P. / Kellmann, M. et al. | 2007
- 16
-
37:The allo-reactivity of donor T-cells is shaped by the presence of immunostimulatory or immunosuppressive donor dendritic cell subsets in the graft: Implications for GvHD and GvL in BMTSoutherland, L. T. / Li, J. M. / Waller, E. K. et al. | 2007
- 17
-
39:Differential impact of mTOR inhibition on FoxP3+ regulatory T cells as compared to conventional T cells after allogeneic bone marrow transplantationZeiser, R. / Leveson-Gower, D. B. / Zambricki, E. A. / Hou, J. Z. / Negrin, R. et al. | 2007
- 17
-
40:Human leukocyte antigen (HLA) haplotypes and single HLA antigens in HLA-matched allogeneic hematopoietic stem cell transplantation (alloHSCT) for myeloid diseases: Analysis of overall and progression free survival (OS/PFS)Aggarwal, C. / Gupta, S. / McCarthy, P. L. / Battiwalla, M. / Hahn, T. E. et al. | 2007
- 17
-
Lymphoid Reconstruction and VaccinesGress, R. E. / Komanduri, K. V. / Einsele, H. / Cooper, L. J. et al. | 2007
- 18
-
43:A subpopulation of human NK cells lacking inhibitory receptors for self MHC is developmentally immature rather than autoreactiveCooley, S. A. / Xiao, F. / Bergemann, T. L. / Pitt, M. / Gleason, M. / McCullar, V. / McQueen, K. / Guethlein, L. / Parham, P. / Miller, J. S. et al. | 2007
- 18
-
41:Long-term follow up of T cell depleted transplants from unrelated donors in pediatric patientsHale, G. A. / Krance, R. A. / Khan, S. P. / Rochester, R. / Horwitz, E. M. / Turner, V. / Gee, A. P. / Brenner, M. K. / Heslop, H. E. et al. | 2007
- 18
-
42:Insulin-like growth factor I positively regulates thymic function by expansion of thymocyte precursors and thymic epithelial cellsChu, Y. W. / Schmitz, S. / Choudhury, B. / Gress, R. E. et al. | 2007
- 19
-
45:Direct isolation and infusion of donor-derived CMV-specific T cells for treatment or prophylaxis of CMV infection following allogeneic transplantationLowdell, M. W. / Thomson, K. / Julie, A. / Pang, K. / Samuel, E. / Desborough, M. / Mackinnon, S. et al. | 2007
- 19
-
44:Pre-clinical study of the effect of the As-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost vaccine in elderly recipients for suppression of recurrent cancer following allografting and donor lymphocyte infusions (DLI)Tang, Y. / Akbulut, H. / Maynard, J. / Petersen, L. / Deisseroth, A. et al. | 2007
- 19
-
46:Thymic shielding (TS) in recipients of total body irradiation (TBI) and alternative donor hematopoietic stem cell transplant (AD-HSCT): Reduced risk of opportunistic infection in patients with fanconi anemia (FA)MacMillan, M. L. / Blazar, B. R. / DeFor, T. E. / Dusenbery, K. R. / Wagner, J. E. et al. | 2007
- 20
-
48:Transplant conditions determine the contribution of homeostatically expanded donor CD8 cells to host lymphoid reconstitution following hematopoietic cell transplantationRoskos, M. / Levy, R. B. et al. | 2007
- 20
-
49:Haplotype mismatched myeloablative stem cell transplantation: Phase I clinical trial of donor lymphocyte infusion depleted of alloreactive T cells to limit infections and malignant relapse without causing GVHDRoy, D. C. / Cohen, S. / Busque, L. / Fish, D. / Kiss, T. / Lachance, S. / Sauvageau, G. / Caudrelier, P. / Roy, J. et al. | 2007
- 20
-
47:CD4+CD25+ regulatory T cells enhance immune reconstitution following allogeneic hematopoietic cell transplantation by protecting thymic and lymphoid compartments from graft-versus-host disease damage without impacting T cell repertoire developmentNguyen, V. H. / Chang, D. / Shashidhar, S. / Bachmann, M. / Contag, C. H. / Brown, J. M. / Negrin, R. S. et al. | 2007
- 21
-
50:Enhanced depletion of alloreactive T cells using combined CD25/71 immunomagnetic selectionSamarasinghe, S. / Karlsson, H. / Nawroly, N. / Openshaw, P. / Veys, P. / Amrolia, P. et al. | 2007
- 21
-
52:Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation (HCT): A report from the bone marrow transplant survivor study (BMT-SS)Baker, K. S. / Ness, K. / Weisdorf, D. / Francisco, L. / Carter, A. / Sun, C. L. / Forman, S. / Bhatia, S. et al. | 2007
- 21
-
51:Androgen withdrawal modulates thymopoiesis by inducing thymic epithelial cell proliferation and enhancing thymocyte development prior to increasing precursor immigrationWilliams, K. M. / Chu, Y. W. / Tayler, E. / Gress, R. E. et al. | 2007
- 22
-
54:Hematopoietic cell transplantation-comorbidity index (HCT-CI): A valid tool to predict morbidity risk in patients undergoing autologous HCT (AHCT) for lymphomaKassar, M. / Shell, K. / Gregory, S. A. / Venugopal, P. / Shammo, J. / Fung, H. C. et al. | 2007
- 22
-
53:Access to hematopoietic stem cell transplantation: Effect of race and genderJoshua, T. V. / Rizzo, J. D. / Zhang, M. J. / Horowitz, M. M. et al. | 2007
- 23
-
57:Outcomes for allogeneic transplantation in imatinib-refractory chronic myeloid leukaemia (CML) are equivalent to outcomes in imatinib-responsive/imatinib-naive CML and can be predicted by the EBMT risk scoreDurrant, S. T. / Stylian, S. / Western, R. J. / Morton, J. P. / Butler, J. / Hutchins, C. / Hill, G. / Kennedy, G. A. et al. | 2007
- 23
-
Dendritic Cells in Transplantation and Immune-Based TherapiesYoung, J. W. / Merad, M. / Hart, D. N. et al. | 2007
- 23
-
55:Alloanatigenic reactions after hematopoietic cell transplantation (HCT) induce genomic alterations in epithelial cells as shown in human studies and in an in vitro modelSpyridonidis, A. / Faber, P. / Petrikkos, L. / Bertz, H. / Finke, J. et al. | 2007
- 23
-
56:Quantifying the survival benefit of allogeneic stem cell transplant in the management of relapsed acute myeloid leukemiaArmistead, P. M. / De Lima, M. / Pierce, S. / Giralt, S. / Champlin, R. / Estey, E. et al. | 2007
- 24
-
58:mTOR inhibitors (MTI) are synergistic with methotrexate: An effective combination to both prevent post-HSCT relapse of all and prevent GVHDTeachey, D. T. / Brown, V. I. / Fish, J. / Reid, G. / Grupp, S. A. et al. | 2007
- 24
-
60:A high lactate dehydrogenase (LDH) level predicts for shorter survival following HLA-matched sibling bone marrow transplant (BMT) for patients with acute myelogenous leukemia (AML)Kalaycio, M. / Rybicki, L. / Pohlman, B. / Dean, R. / Sweetenham, J. / Andresen, S. / Sobecks, R. / Sekeres, M. / Advani, A. / Brown, S. et al. | 2007
- 24
-
59:GM-CSF secreting leukemia cell vaccinations after allogeneic reduced-intensity peripheral blood stem cell transplantation (SCT) for advanced myelodysplastic syndrome (MDS) or refractory acute myeloid leukemia (AML)Ho, V. T. / Dranoff, G. / Kim, H. / Pasek, M. / Cutler, C. / Koreth, J. / Alyea, E. P. / Antin, J. H. / Soiffer, R. J. et al. | 2007
- 25
-
61:NOD2/CARD15 gene single nucleotide polymorphisms are associated with significant increases in mortality due to increases in disease relapse in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemiaMayor, N. P. / Shaw, B. E. / Hughes, D. A. / Maldonado-Torres, H. / Madrigal, J. A. / Keshav, S. / Marsh, S. G. et al. | 2007
- 25
-
62:Two-year follow-up results at the M.D. Anderson Hospital with reduced-intensity allogeneic stem cell transplantation with fludarabine-melphalan as preparative regimen in relapsed/refractory Hodgkin’s lymphomaAnderlini, P. / Saliba, R. / Acholonu, S. / Giralt, S. A. / Khouri, I. F. / Andersson, B. / De Lima, M. / Hosing, C. / Champlin, R. E. et al. | 2007
- 26
-
64:Interleukin-6 and hematopoietic soluble factors confers resistance to trail mediated apoptosisPerez, L. E. / Parquet, N. / Shain, K. / Molisano, M. / Nimmanapalli, R. / Alsina, M. / Anasetti, C. / Dalton, W. et al. | 2007
- 26
-
63:Vaccination with dendritic cell myeloma fusions alone or in conjunction with stem cell transplantation for patients with multiple myelomaAvigan, D. / Rosenblatt, J. / Vasir, B. / Wu, Z. / Bisonette, A. / Macnamarra, C. / Uhl, L. / Lenahan, C. / Miller, K. / Joyce, R. et al. | 2007
- 26
-
65:The use of cyclophosphamide (CY), fludarabine and ATG as a preparative regimen for unrelated cord blood transplantation (UCBT) in fanconi anemia: A single center experience in 27 patientsBonfim, C. / Bitencourt, M. / Setubal, D. / Funke, V. / Ruiz, J. / Oliveira, M. / Coutinho, E. / deMedeiros, C. / Zanis-Neto, J. / Pasquini, R. et al. | 2007
- 26
-
Clinical Utility of Autopsy after Hematopoietic Stem Cell TransplantationHofmeister, C. C. / Marinier, D. E. / Czerlanis, C. / Stiff, P. J. et al. | 2007
- 27
-
66:Outcomes of allogeneic hematopoietic stem cell transplantation in pediatric patients with hematologic malignancies following single-dose total body irradiationDruley, T. E. / Hayashi, R. J. / Barnes, Y. J. / Jean, Z. / David, M. / Kathryn, T. / Shannon, W. / Tia, T. / Eric, K. / John, D. F. et al. | 2007
- 27
-
67:Chest radiograph versus computed tomography in the diagnosis of acute pulmonary complications in pediatric stem cell transplantDuncan, C. N. / Buonanno, M. P. / Cormier, C. / Lehmann, L. E. et al. | 2007
- 28
-
69:Therapeutic monitoring of sirolimus is essential in pediatric BMT recipientsGoyal, R. K. / Venkataramanan, R. / Krasowski, M. / Sindhi, R. / Zorich, G. P. / Grupp, S. / Wall, D. / Bunin, N. / Pulsipher, M. A. et al. | 2007
- 28
-
70:Defibrotide for the treatment of Sinusoidal Obstruction Syndrome (SOS) following hematopoietic stem cell transplant in pediatric patientsHill, A. B. / Robertson, K. A. / Gowan, D. J. / Lorch, C. / Collura, J. M. / Renbarger, J. / Goebel, W. S. / Haut, P. P. et al. | 2007
- 28
-
68:Human polyomavirus BK and JC infection in children after hematopoietic stem cell transplantation: Analysis of risk factors contributing to viruses reactivation and hemorrhagic cystitisGorczynska, E. / Turkiewicz, D. / Rybka, K. / Toporski, J. / Kalwak, K. / Dyla, A. / Owoc-Lampach, J. / Wojcik, D. / Ussowicz, M. / Slociak, M. et al. | 2007
- 29
-
73:Low rates of toxicity and long-term responses after bu/flu/ATG RIC allogeneic transplantation in very high risk pediatric patients ineligible for myelablative therapy: A Pediatric Blood and Marrow Transplant Consortium StudyPulsipher, M. A. / Goyal, R. / Frangoul, H. / Shaw, P. / Haight, A. / Kadota, R. / Wall, D. / Grupp, S. / Kletzel, M. et al. | 2007
- 29
-
72:Effective immunotherapy for neuroblastoma requires HSCT and T cell transferOrentas, R. J. / Jing, W. / Yan, X. / Johnson, B. D. et al. | 2007
- 29
-
71:Virus-specific T cells engineered to co-express tumor-specific receptors; effects in patients with neuroblastomaMyers, G. D. / Pule, M. A. / Russell, H. / Liu, E. / Weiss, H. L. / Dotti, G. / Lopez, T. / Rooney, C. M. / Heslop, H. E. / Brenner, M. K. et al. | 2007
- 30
-
76:Reduced intenity allogeneic stem cell transplantion followed by targeted consolidation immunotherapy with gemtuzumab ozogamicin in children and adolescents with CD33+ acute myeloid leukemiaRoman, E. / Cooney, E. / Militano, O. / Wolownik, K. / Hawkes, R. / Foley, S. / Satwani, P. / Guerra, J. / Bhatia, M. / Bradley, B. et al. | 2007
- 30
-
74:Sirolimus (SRL)-based GVHD prophylaxis to decrease relapse in pediatric related and unrelated transplant recipients with very high-risk all: Preliminary results of a multi-institutional pilot studyPulsipher, M. A. / Wall, D. / Goyal, R. / Bunin, N. / Grupp, S. et al. | 2007
- 30
-
75:A novel antibody-based minimal intensity conditioning regimen for children with severe organ toxicity or DNA repair disordersRao, K. / Hale, G. / Brenner, M. K. / Davies, G. E. / Veys, P. / Amrolia, P. J. et al. | 2007
- 31
-
What’s Past Is Prologue: Lessons Learned and the Need for Further Development of Allogeneic Hematopoietic Stem Cell Transplantation for Renal Cell CarcinomaUeno, N. T. / Childs, R. W. et al. | 2007
- 31
-
78:Hematopoietic cell transplantation (HCT) in children with acute lymphocytic leukemia (ALL) in second complete remission (CR2): Similar results with grafts from unrelated donors (URD) and HLA matched sibling donors (MSD)Smith, A. P. / Baker, K. S. / DeFor, T. E. / Verneris, M. P. / Wagner, J. E. / MacMillan, M. L. et al. | 2007
- 31
-
77:Non-invasive PET imaging of T cells derived from umbilical cord bloodSingh, H. / Najjar, A. M. / Olivares, S. / Nishii, R. / Mukhopadhyay, U. / Alauddin, M. / Jensen, M. C. / Forman, S. J. / Shpall, E. J. / Champlin, R. E. et al. | 2007
- 32
-
81:Enhancing the in vivo expansion of adoptively transferred EBV-CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsLouis, C. U. / Straathof, K. / Torrano, V. / Huls, M. H. / Gresik, M. V. / Weiss, H. / Gee, A. / Brenner, M. K. / Rooney, C. M. / Heslop, H. E. et al. | 2007
- 32
-
79:Directed donor cord blood transplantation for hematological disordersWalters, M. C. / Quirolo, L. / Edwards, S. / Lee, J. / Robertson, S. / Falcon, K. / Briddell, R. / Lubin, B. et al. | 2007
- 32
-
80:High avidity cyclin E-derived peptide-specific CTL contribute to induction of remission after stem cell transplantationIshiyama, K. / Kondo, Y. / Wieder, E. / Lu, S. / Molldrem, J. et al. | 2007
- 33
-
83:Incidence and mortality of invasive fungal infections in high-risk patients receiving posaconazole versus fluconazole or itraconazole prophylaxisLangston, A. / Lipton, J. H. / Cornely, O. A. / Ullmann, A. J. / Patino, H. / Hardalo, C. / Winston, D. J. / Chandrasekar, P. et al. | 2007
- 33
-
Adoptive Therapy with T Cells/NK CellsCooley, S. / June, C. H. / Schoenberger, S. P. / Miller, J. S. et al. | 2007
- 33
-
82:Regulation of initial self-renewing divisions of hematopoietic stem cells by human mesenchymal stromal cellsWagner, W. / Wuchter, P. / Gottschling, S. / Eckstein, V. / Ho, A. D. et al. | 2007
- 34
-
85:NOD FC exhibit significantly impaired functionFugier-Vivier, I. J. / Huang, Y. / Miller, T. / Tanner, M. K. / Chilton, P. M. / Ildstad, S. T. et al. | 2007
- 34
-
84:Prevention and reversal of lupus in NZB/NZW mice by transplantation of purified allogeneic hematopoietic stem cells (HSC) with non-myeloablative conditioning (NMT)Smith-Berdan, S. / Gille, D. / Christensen, J. L. et al. | 2007
- 34
-
Hematopoietic Stem Cell Recipients Do Not Develop Post-transplantation Immune Tolerance to Antigens Present on Minimal Residual DiseaseMartinelli Natzke, A. / Shaw, J. L. / McKeller, M. R. / Lambert Emo, K. / Mullen, C. A. et al. | 2007
- 34
-
86:Hematopoietic stem cell transplantation (HCT) for autoimmune diseases (AI): Review of transplants performed in North and South America and reported to the Center for International Blood and Marrow Transplantation (CIBMTR)Mcsweeney, P. A. / Pasquini, M. C. / Kukreja, M. / Bredeson, C. / Nash, R. / Horowitz, M. M. / Atkins, H. et al. | 2007
- 35
-
87:Autologous hematopoietic stem cell transplantation (AHSCT) for early onset type I Diabetes mellitusMoraes, D. A. / Oliveira, M. C. / Stracieri, A. B. / Couri, C. E. / Barros, G. M. / Pieroni, F. / Coutinho, M. A. / Foss, M. C. / Simoes, B. P. / Voltarelli, J. C. et al. | 2007
- 35
-
88:Serial skin biopsies demonstrate reduced dermal fibrosis after autologous hemopoietic stem cell transplant (A-HSCT) for severe systemic sclerosis (SSS)Shulman, H. M. / Nash, R. A. et al. | 2007
- 35
-
89:Prevention of mucositis in auto BMT/stem cell transplant patientsKlocke, J. / Cannon, M. / Gissenger, D. / Devoe, C. / John, V. / Bayer, R. L. et al. | 2007
- 36
-
90:Role of high-dose chemotherapy with autologous stem cell transplantation in primary systemic amyloidosis: A systematic reviewBehera, M. / Kharfan-Dabaja, M. A. / Kumar, A. / Soares, H. P. / Djulbegovic, B. et al. | 2007
- 36
-
91:Dose dense dreifach* melphalan100 for multiple myelomaBerz, D. / McCormack, E. / Winer, E. / Karwan, P. / Colvin, G. / Rathore, R. / Larry, L. / Elfenbein, G. / Quesenberry, P. et al. | 2007
- 36
-
92:Outcomes associated with age in patients with malignant lymphoma receiving autologous stem cell transplantBeveridge, C. A. / Ershler, W. B. / Orloff, G. J. / Sheridan, M. J. / Shelton, M. V. et al. | 2007
- 37
-
95:Autologous hematopoietic cell transplantation (auto-HCT) in chronic lymphocytic leukemia (CLL): Results of a systematic reviewKharfan-Dabaja, M. A. / Kumar, A. / Behera, M. / Field, T. / Ayala, E. / Perez, L. / Fernandez, H. / Anasetti, C. / Djulbegovic, B. et al. | 2007
- 37
-
93:Outcome with a thiotepa containing regimen and autologous HSCT in patients with NHLCumpston, A. D. / Bulian, D. A. / Kanate, A. / Weisenborn, R. / Bunner, P. / Visweshwar, N. I. / Craig, M. / Ericson, S. G. et al. | 2007
- 37
-
94:Immune mobilization of autologous peripheral blood progenitor cells: IL-2 with GM-CSF and G-CSF results in effective mobilization without delay in engraftmentHill, J. M. / Wu, J. Y. / Webber, S. / Sharlin, O. / Ernstoff, M. S. / Szczepiorkowski, Z. M. / Meehan, K. P. et al. | 2007
- 38
-
97:Rituximab-related late-onset neutropenia after autologous stem cell transplantation for malignant lymphomaNagafuji, K. / Numata, A. / Yoshimoto, G. / Harada, N. / Harada, M. et al. | 2007
- 38
-
96:Autologous blood stem cell transplantation: Regimen related complications and transplant outcomeKumar, L. / Ganessan, K. / Khatry, N. / Sengar, M. / Sharma, A. et al. | 2007
- 39
-
99:Single-center experience with the early use of AMD3100 plus G-CSF for mobilization of hematopoietic progenitor cells in patients classified as poor mobilizersRoberts, C. H. / Chung, H. M. / Candler, K. S. / Calandra, G. / Badel, K. / McCarty, J. M. et al. | 2007
- 39
-
98:T-cell large granular lymphocytosis following autologous stem cell transplantRichard, S. / Golightly, M. / Gladstone, D. E. / Spitzer, S. G. / Zamkoff, K. W. et al. | 2007
- 39
-
100:Hematopoietic stem cell transplantation with autologous cord blood units in two patients with severe aplastic anemia: Time for reassessment?Rosenthal, J. / Bolotin, E. / Pawlowska, A. / Falk, P. / Oliver, C. / Forman, S. et al. | 2007
- 40
-
102:Implications of body weight calculations for autologous peripheral blood stem cell transplantationSimpson, L. / Wolfe, R. C. / Gastineau, D. A. / Hogan, W. J. / Kumar, S. et al. | 2007
- 40
-
101:High-dose chemotherapy with autologous stem cell transplantation in 61 patients with light chain amyloidosis: A single centre experienceSchonland, S. O. / Dengler, J. B. / Bochtler, T. / Goldschmidt, H. / Ho, A. D. / Hegenbart, U. et al. | 2007
- 40
-
103:Poor outcome of autologous-bone marrow transplant (auto-BMT) following failed peripheral blood stem cell (PBSC) mobilizationStrickland, S. A. / Chen, H. / Hunt, C. / Chinratanalab, W. / Engelhardt, B. / Goodman, S. A. / Greer, J. P. / Kassim, A. A. / Morgan, D. S. / Ruffner, K. L. et al. | 2007
- 41
-
104:An audited retrospective analysis of cord blood transplantation (CBT) of 230 patients using plasma depleted cord blood units (PD CB)Chow, R. / Wang, B. / Wu, T. / Chow, T. / Gjertson, D. / Petz, L. et al. | 2007
- 41
-
105:A pilot study CD34 selected haploidentical transplant using a chemotherapy only preparative regimen and intensive antibiotic prophylaxis for treatment of advanced leukemiaGajewski, J. L. / McMannis, J. D. / Shpall, E. J. / Donato, M. L. / Champlin, R. E. et al. | 2007
- 41
-
106:Combined bone marrow and PBPC autografts for transplantation of patients with poor mobilizationSinitsyn, Y. / Grosskreutz, C. / Osman, K. / Scigliano, E. / Isola, L. et al. | 2007
- 42
-
107:Evidence of successful allogeneic transplantaiton using cryopreserved peripheral blood stem cells from healthy donorsKim, D. H. / Jamal, N. / Saragosa, R. / Lipton, J. H. / Gupta, V. / Kuruvilla, J. / Messner, H. A. et al. | 2007
- 42
-
109:A pilot trial of unrelated donor umbilical cord blood transplanation (UCBT) augmented with cytokine-primed aldehyde dehydrogenase-bright (ALDHbr) cellsKurtzberg, J. / Balber, A. / Mendizabal, A. / Reese, M. / Kaestner, A. / Gentry, T. / Hickerson, D. / Allen, C. / Sledge, L. S. / Deibert, E. et al. | 2007
- 42
-
108:Development of a minimally invasive device and method for rapid, outpatient harvest of bone marrowKraft, D. / Milroy, C. / MacKenzie, A. / Ghazarossian, V. et al. | 2007
- 43
-
110:Validation study of mononuclear cell recovery using the AXP™ AutoXpress™ PlatformLi, J. / Zhu, H. / Nguyen, M. / Emmanuel, P. / Baker, B. / Marr, D. / Weatherford, C. / Chapman, J. et al. | 2007
- 43
-
111:A comparison of the traditional water-bath vs. dry thawing method for thawing cryopreserved peripheral stem cell components with a goal of reducing the contamination risksMerkel, D. / Trieu, K. et al. | 2007
- 43
-
112:Rigorous protocols using Alemtuzumab to T cell deplete stem cell productsTalmadge, J. E. / Gulen, D. / Bociek, R. G. et al. | 2007
- 43
-
Endothelial Biology and the Bone MarrowCuddihy, A. R. / Crooks, G. M. et al. | 2007
- 44
-
114:Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of irradiated miceMuramoto, G. G. / Himburg, H. / Salter, A. / Meadows, S. / Chen, B. / Rickman, D. / Chao, N. J. / Chute, J. P. et al. | 2007
- 44
-
115:Mesenchymal stem cells are effective at preventing but not at treating GVJDTisato, V. / Naresh, K. / Navarrete, C. / Dazzi, F. et al. | 2007
- 44
-
113:Comparison of cell dose and outcome for cord blood transplantation (CBT) sourced from plasma depleted (PD) versus red cell depleted (RD) cord blood inventoriesWang, B. / Tsukahara, E. / Wu, T. / Chow, T. / Lin, A. / Gjertson, D. / Petz, L. / Chow, R. et al. | 2007
- 45
-
117:Naive and memory T regulatory cells respond to mesenchymal cells regulationDi Ianni, M. / Del Papa, B. / Cecchini, D. / Moretti, L. / Bonifacio, E. / De Ioanni, M. / Bazzucchi, F. / Zei, T. / Sportoletti, P. / Falzetti, F. et al. | 2007
- 45
-
118:Co-transplanation of haploidentical mesenchymal stem cells to overcome graft dysfunction associated with parental haploidentical CD34 postive selected peripheral stem cell graftsBall, L. M. / Kollen, W. J. / Bernado, M. E. / Lankester, A. / Roelofs, H. / Locatelli, F. / Fibbe, W. E. / Egeler, R. M. et al. | 2007
- 45
-
116:Multipotential mesenchymal stromal cells (MMSC) abrogate acute graft-versus-host disease in a murine modelLacy, J. / Jackson, J. / Murphy, B. / Sharp, G. / Devetten, M. et al. | 2007
- 46
-
120:Long term engraftment after allogeneic transplantation for beta-thalassemia major: Evidence for a role of CD3 cells early after transplantationNuernberger, W. A. / Thiele, B. / Kraut, L. / Fauser, A. A. et al. | 2007
- 46
-
119:Co-transplantation of mesenchymal stem cells and hematopoietic stem cellsLe Blanc, K. / Sundberg, B. / Lonnies, H. / Aschan, J. / Barkholt, L. / Gustafsson, B. / Ringden, O. et al. | 2007
- 46
-
121:Mesenchymal stem cells for treatment of steroid-resistant graft-versus-host diseaseHo, S. J. / Dyson, P. / Rawling, T. / Stevens, J. / Patton, N. / To, L. B. / Lewis, I. et al. | 2007
- 46
-
An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell TransplantationAsavaroengchai, W. / Wang, H. / Wang, S. / Wang, L. / Bronson, R. / Sykes, M. / Yang, Y. G. et al. | 2007
- 47
-
124:Molecular composition of cell-cell contact between hematopoietic stem cells and mesenchymal stem cellsWagner, W. / Wein, F. / Roderburg, C. / Benes, V. / Frankhauser, M. / Wuchter, P. / Eckstein, V. / Ho, A. D. et al. | 2007
- 47
-
Cancer Stem Cells: From Bench to BedsideJones, R. J. / Matsui, W. et al. | 2007
- 47
-
123:Regulation of hematopoietic colony forming cells by CD4+CD25+ T cells: A role for T regulatory cells in hematopoiesisUrbieta, M. / Barao, I. / Murphy, W. J. / Blazar, B. / Jones, M. / Levy, R. B. et al. | 2007
- 47
-
122:Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colonRingden, O. / Uzunel, M. / Sundberg, B. / Lonnies, L. / Nava, S. / Gotherstrom, C. / Gustafsson, J. / Henningsohn, L. / Le Blanc, K. et al. | 2007
- 48
-
126:Hematopoietic stem cell transplantation (SCT) in Fanconi Anemia (FA) patients: How long is long term follow-up?Bonfim, C. / Bitencourt, M. / deMedeiros, C. / Setubal, D. / Ruiz, J. / Quiroga, M. / Beltrame, M. / Funke, V. / Zanis-Neto, J. / Pasquini, R. et al. | 2007
- 48
-
125:Preventive health behaviors of long-term hematopoietic cell transplant survivorsBishop, M. M. / Beaumont, J. L. / Lee, S. J. / Andrykowski, M. A. / Rizzo, J. D. / Wingard, J. R. et al. | 2007
- 48
-
127:Gene expression signatures that predict human radiation exposureMeadows, S. / Dressman, H. / Muramoto, G. / Chao, N. J. / Ginsburg, G. / Nevins, J. P. / Chute, J. P. et al. | 2007
- 49
-
130:The incidence of secondary malignancy after stem cell transplantation, the importance of total body irradiationGhavamzadeh, A. / Samiee, S. / Mahdavi, N. / Bakhti, O. / Jahani, M. / Alimoghaddam, K. / Iravani, M. / Bahar, B. / Khodabandeh, A. / Mousavi, A. et al. | 2007
- 49
-
128:High prevalence of bone loss in long term survivors following allogeneic bone marrow and peripheral blood stem cell transplantationDonohue, T. B. / Savani, B. N. / Shenoy, A. / Kozanas, E. / Singh, A. K. / Childs, R. W. / Barrett, A. J. et al. | 2007
- 49
-
129:15 years hematopoietic stem cell transplantation for beta Thalassemia Major in TehranGavamzadeh, A. / Ali Mogaddam, K. / Nedaeifard, L. / Jahani, M. / Mousavi, A. / Iravani, M. / Bahar, B. et al. | 2007
- 50
-
132:Late effects in survivors of Hodgkin’s and non-Hodgkin’s lymphoma treated with autologous hematopoietic cell transplantation: A report from the bone marrow transplant survivor studyMajhail, N. S. / Ness, K. K. / Burns, L. J. / Carter, A. / Francisco, L. / Sun, C. L. / Forman, S. J. / Bhatia, S. / Baker, K. S. et al. | 2007
- 50
-
131:A new conditioning regimen in Thalassemia major class 3 an experience of Iran from 2004 till 2006Iravani, M. / Alimogaddam, K. / Khatami, F. / Jalili, M. / Tagipur, R. / Bab hadiashar, N. / Gaffari, F. / Mousavi, A. / Jahani, M. / Bahar, B. et al. | 2007
- 50
-
133:5 cases of permanent alopecia after various conditioning regmiens commonly used in bone marrow transplantationMachado, M. / Moreb, J. / Khan, S. A. et al. | 2007
- 51
-
134:No evidence for increased transplant related toxicity in Ph+ chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) with prior exposure to DasatinibLeiba, M. / Shimoni, A. / Guilhot, F. / Martineau, G. / Renaud, M. / Francois, S. / Hardan, I. / Nagler, A. et al. | 2007
- 51
-
136:Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation in Brazil: Incidence, clinical features and influence of tuberculosisFermino, F. A. / Oliveira, J. S. et al. | 2007
- 51
-
135:Once-daily administration of modified-release tacrolimus capsule (MR) for the prophylaxis of graft-versus-host-disease (GVHD) after unrelated donor bone marrow transplantation (BMT)Okamoto, S. / Gondo, H. / Imamura, M. / Kodera, Y. et al. | 2007
- 52
-
139:A journey to performance excellence utilizing the Malcolm Baldrige model in a bone marrow transplant unitSchriber, J. P. / Majkowski, G. O. / Kendrick, S. / Simpson, E. / Sarkodee-Adoo, C. / Briggs, A. D. / Forman, S. J. / Alvarnas, J. C. et al. | 2007
- 52
-
138:Hypothyroidism in long-term survivors after TBI based allogeneic stem cell transplantations – impact of chronic graft versus host disease and TBI doseSavani, B. N. / Shenoy, A. / Kozanas, E. / Wisch, L. / Singh, A. K. / Childs, R. / Barrett, A. J. et al. | 2007
- 52
-
137:End-of-life care in hematology and stem cell transplant patients and evaluation of a hematology-quality of dying assessment (H-QODA)Rowlings, P. / Zhang, H. / Rohr, Y. et al. | 2007
- 52
-
140:A survey of hematopoietic cell transplant survivors and spouses: What are the major issues of concern post-transplant?Stewart, S. K. et al. | 2007
- 53
-
Mesenchymal Stromal CellsHorwitz, E. M. / Andreef, M. / Frassoni, F. et al. | 2007
- 53
-
141:P53 mutations in secondary malignancies after allogeneic hematopoietic cell transplantationZouvelou, C. / Bertz, H. / Faber, P. / Finke, J. / Spyridonidis, A. et al. | 2007
- 53
-
142:Low dose thalidomide maintenance in myeloma patients after autologous stem cell transplantationBayer, R. L. / John, V. / Devoe, C. / Cannon, M. / Klocke, J. / Gissinger, D. et al. | 2007
- 54
-
143:Comparison of multiple myeloma patients treated with autologous stem cell transplant having received Thal Dex or VADBeveridge, C. A. / Orloff, G. J. / Sheridan, M. J. / Shelton, M. V. et al. | 2007
- 54
-
144:Autologous stem cell transplantation (ASCT) for patients with multiple myeloma (MM): Impact of the degree of plasma cell bone marrow infiltration on mobilization kinetic and transplant outcomesGo, A. / Gregory, S. A. / Venugopal, P. / Shammo, J. / McLeod, B. / Fung, H. C. et al. | 2007
- 55
-
145:ID/KLH active immunotherapy (FAVID®) following high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for non-hodgkin’s lymphoma (NHL)Holman, P. P. / deMagalhaes-Silverman, M. / Corringham, S. / Castro, J. E. / Carrier, E. / Lane, T. / Gold, D. / Ball, E. et al. | 2007
- 55
-
147:Improved outcome of patients with mantle cell lymphoma (MCL) in first remission (CR1) after hematopoietic stem cell transplantationKassim, A. / Jagasia, M. / Dixon, S. / Chinratanalab, W. / Morgan, D. / Ruffner, K. / Greer, J. / Stein, R. / Engelhardt, B. / Goodman, S. et al. | 2007
- 55
-
146:Use of a novel organic arsenic (ZIO-101) after autotransplants for multiple myelomaHussein, M. A. / Belch, A. / Boccia, R. V. / Barlogie, B. / Campbell, R. / Boise, L. H. / Schwartz, B. / Gale, R. P. / Berenson, J. P. et al. | 2007
- 56
-
150:A randomized phase I trial of melphalan + bortezomib as conditioning for autologous transplant for myeloma: The effect of sequence of administrationLonial, S. / Kaufman, J. / Langston, A. A. / Khoury, H. J. / Torre, C. / Lechowicz, M. J. / Flowers, C. / Waller, E. K. et al. | 2007
- 56
-
148:Salvage and disease control of aggressive histology non-Hodgkin’s lymphoma by allogeneic stem cell transplantationKuruvilla, J. / Bao, Q. / Suski, A. / Gupta, V. / Lipton, J. H. / Minden, M. D. / Messner, H. A. et al. | 2007
- 56
-
Pharmacokinetics of Once-Daily IV Busulfan as Part of Pretransplantation Preparative Regimens: A Comparison with an Every 6-Hour Dosing ScheduleMadden, T. / de Lima, M. / Thapar, N. / Nguyen, J. / Roberson, S. / Couriel, D. / Pierre, B. / Shpall, E. J. / Jones, R. B. / Champlin, R. E. et al. | 2007
- 56
-
149:Nonmyeloablative stem cell transplantation in patients with relapsed or refractory Hodgkin lymphoma: Poor evidence of an efficacious graft-versus-Hodgkin’s lymphoma effectLerner, D. / Azevedo, A. M. / Tavares, R. d. / Nogueira, M. C. / Maiolino, A. / Bouzas, L. F. et al. | 2007
- 57
-
152:Efficacy and toxicity of a second autologous peripheral blood stem cell transplant for patients with relapsed or recurrent multiple myelomaPatel, R. C. / Burzynski, J. A. / Ochoa-Bayona, J. L. / Toro, J. / Greene, R. E. / Freytes, C. O. et al. | 2007
- 57
-
151:Immunotherapy immediately following transplantation for multiple myeloma: Early recovery of aggressive cytotoxic cells and improved immune resurgenceMeehan, K. P. / Bengtson, E. / Wu, J. Y. / Ely, P. / Hill, J. M. / Szczepiorkowski, Z. M. / Ernstoff, M. et al. | 2007
- 57
-
153:Phase I/II trial of bortezomib maintenance following autologous peripheral blood progenitor cell transplantation as treatment for intermediate- and advanced-stage multiple myelomaSchiller, G. J. / Sohn, J. P. / Malone, P. / Bartoni, K. / Habtemariam, B. / Paquette, P. / deVos, S. / Territo, M. et al. | 2007
- 58
-
156:Once-daily intravenous busulfan versus oral busulfan in children prior to stem cell transplantation: Study of pharmacokinetics and clinical outcomesBoelens, J. J. / Bartelink, I. / Bredius, R. / Zwaveling, J. / Bierings, M. / Rademaker, K. / Ververs, T. / van Kesteren, C. et al. | 2007
- 58
-
Emerging Targets for Hematopoietic Cell Transplantation (HCT): Genetic Disorders of Hematopoiesis and ImmunityFilipovich, A. H. / Bleesing, J. / Goldman, F. et al. | 2007
- 58
-
155:Characteristics of the pediatric blood and marrow transplant advanced practice nurseBarnes, Y. J. / Fisher, V. L. / Olson, E. et al. | 2007
- 58
-
154:Allogeneic transplantation for Wiskott Aldrich Syndrome using a reduced intensity conditioning regimenBarnes, Y. J. / Hayashi, R. J. / Witty, S. / Shenoy, S. et al. | 2007
- 59
-
159:Job satisfaction among advanced practice nurses within the Pediatric Blood and Marrow Transplant ConsortiumBrowning, B. / Thormann, K. / Coyne, K. / Halverson, T. et al. | 2007
- 59
-
158:Clinical outcome of human herpes-6 reactivation after haematopoietic stem cell transplantation in childrende Pagter, A. / Sanders, L. / Rossen, J. / Schuurman, R. / Wolfs, T. / Versluys, B. / Boelens, J. J. et al. | 2007
- 59
-
157:Outcomes of cord blood transplantation for Hurler’s syndrome. An EUROCORD-working party inborn errors EBMT surveyBoelens, J. J. / Bierings, M. / Wynn, R. / O’ / Meara, A. / Veys, P. / Bertrand, Y. / Wraith, E. / Cavazzana-Calvo, M. / Wulffraat, N. et al. | 2007
- 60
-
160:Fasciitis as a manifestation of chronic graft versus host disease following allogeneic hematopoietic stem cell transplantation in children and adolescents: A single institution experienceDuncan, C. N. / Myers, K. L. / Lehmann, L. E. et al. | 2007
- 60
-
161:Severe veno-occlusive disease after bone marrow transplantation in premature monozygotic twins with familial hemophagocytic lymphohistiocytosis (FLH)Ehlert, K. / Florax, A. / Worch, J. / Roessig, C. / Fruehwald, M. C. et al. | 2007
- 61
-
164:Risk adapted allogeneic stem cell transplantation (AlloSCT) for acquired severe aplastic anemia (SAA) in pediatric recipientsGuerra, J. / Garvin, J. / Baldinger, L. / van de Ven, C. / Roman, E. / Bhatia, M. / Satwani, P. / Bradley, M. B. / George, D. / Schwartz, J. et al. | 2007
- 61
-
162:Fludarabine-based reduced-intensity conditioning for allogeneic transplantation in children with malignant and non-malignant diseasesGonzalez, M. / Perez, A. / Ramirez, M. / Sevilla, J. / Madero, L. / Diaz, M. A. et al. | 2007
- 61
-
163:Systemic viral and fungal infections are not significantly decreased following reduced intensity allogeneic stem cell transplantation (RIAlloSCT) in children and adolescent recipients with malignant and nonmalignant diseasesGuerra, J. / Satwani, P. / Baldinger, L. / van de Van, C. / Roman, E. / Garvin, J. / Bradley, M. B. / Bhatia, M. / George, D. / Schwartz, J. et al. | 2007
- 62
-
166:Unrelated cord blood transplantation (UCBT) for transfusion-dependent thalassemia – a retrospective audited analysis of 41 consecutive patientsJaing, T. H. / Tan, P. / Rosenthal, J. / Chan, L. L. / Lin, H. P. / Tan, P. L. / Nademanee, A. / Karanes, C. / Gjertson, D. / Wang, B. et al. | 2007
- 62
-
165:Rate of deline of rabbit anti-thymocyte globlulin (RATG) serum levels in children is related to immune reconstitution and chimerism status after reduced-intensity allogeneic transplantationHorn, B. N. / O’ / Brien, S. / Hwang, J. / Oon, C. Y. / Cowan, M. J. et al. | 2007
- 62
-
167:Relapse following busulfan/cyclophosphamide conditioning in children and adolescents undergoing HLA-identical sibling transplantation for stable phase chronic myeloid leukemiaLehmann, L. E. / Buonanno, M. / Duncan, C. N. et al. | 2007
- 63
-
169:Neurodevelopmental outcomes of children with MPS II after unrelated umbilical cord blood transplantationMaria, E. L. / Michele, P. D. / Vinod, P. / Joanne, K. / Paul, S. et al. | 2007
- 63
-
170:Veno-occlusive disease in pediatric HSCT: The Children’s Oncology Group experienceNieder, M. L. / Hale, G. A. / Wall, D. A. et al. | 2007
- 63
-
168:Neurodevelopmental outcomes of unrelated umbilical cord blood tansplantation for metachromatic leukodystrophyMartin, H. P. / Poe, M. D. / Szabolcs, P. / Martin, P. / Suhag, P. / Vinod, P. / Joanne, K. / Maria, E. L. et al. | 2007
- 64
-
171:Nutritional support: A survey of Pediatric Blood and Marrow Transplant Consortium institutionsOlson, E. A. / Fisher, V. L. / Barnes, Y. J. / Skeens, M. A. / Niess, D. et al. | 2007
- 64
-
172:Post transplant autoimmune hemolytic anemia and other cytopenias are increased in young babies undergoing unrelated donor umbilical cord blood transplantationPage, K. M. / Wood, S. / Prasad, V. / Szabolcs, P. / Kurtzberg, J. et al. | 2007
- 64
-
174:Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndromeParikh, S. H. / Mendizabal, A. / Martin, P. L. / Szabolcs, P. / Prasad, V. K. / Driscoll, T. A. / Kurtzberg, J. et al. | 2007
- 64
-
Philadelphia Chromosome–Negative Myeloproliferative Disorders: Biology and TreatmentHoffman, R. / Prchal, J. T. / Samuelson, S. / Ciurea, S. O. / Rondelli, D. et al. | 2007
- 64
-
173:Outcomes of matched related donor bone marrow transplantation in pediatric patients with myelodysplastic syndromeParikh, S. H. / Martin, P. L. / Prasad, V. K. / Szabolcs, P. / Driscoll, T. A. / Kurtzberg, J. et al. | 2007
- 65
-
175:Myeloablative HSCT for children and adolescents with lymphoma refractory to primary therapy: A single institution experienceQuinones, R. / Peltz, A. / Malcolm, J. / Hild, E. / Gore, L. / Foreman, N. / Christensen, M. / Croskell, M. / Kissane, R. / Giller, R. et al. | 2007
- 65
-
176:Reduced intensity conditioning (RIC) and hematopoietic stem cell transplantatiation (HSCT) using photopheresis (ECP), fludarabine, and targeted single dose busulfan as an outpatient procedure in children: Preliminary resultsSchneiderman, J. / Duerst, R. / Tse, W. / Thormann, K. / Kletzel, M. / Jacobsohn, D. A. et al. | 2007
- 65
-
Advance Care Planning in Patients Undergoing Hematopoietic Cell TransplantationJoffe, S. / Mello, M. M. / Cook, E. F. / Lee, S. J. et al. | 2007
- 66
-
178:HHV-6 infection following Campath1H based reduced intensity conditioning (RIC) regimen in pediatric patients undergoing SCT for non-malignant disordersSoni, S. / Barnes, Y. / Hayashi, R. / Manna, P. / Shenoy, S. et al. | 2007
- 66
-
177:Combined tacrolimus (FK-506) and mycophenolate mofetil (MMF) for graft-versus-host disease (GVHD) prophylaxis in children undergoing cord blood transplantation (CBT)Soni, S. / Hente, M. / Breslin, N. / Bertolone, S. / Cheerva, A. et al. | 2007
- 66
-
179:Unrelated donor umbilical cord blood transplant following intrauterine transfusions for treatment of alpha thalassemia majorRivers, A. E. / Richard, D. / Harris, N. / Chui, D. H. / Slayton, W. B. / Staba, S. L. et al. | 2007
- 67
-
182:Mobilization of PML-RARA negative peripheral blood stem cells and autologous peripheral blood stem cell transplant in pediatric patients with relapsed acute promyelocytic leukemiaTermuhlen, A. M. / Klopfenstein, K. J. / Boyer, M. / Rosselet, R. M. / Altura, R. / Olshefski, R. / Yeager, N. D. / Gross, T. G. et al. | 2007
- 67
-
181:Kinetics of engraftment following dual unrelated cord blood transplantation with reduced intensity conditioningTan, P. L. / Villegas, M. S. / Chan, Y. H. / Yeoh, E. J. / Quah, T. C. et al. | 2007
- 67
-
180:Chronic graft-versus host disease (GVHD) in children with mucopolysacharidoses (MPS) two years after unrelated donor umbilical cord blood transplantation (UCBT)Szabolcs, P. / Martin, P. L. / Parikh, S. / Prasad, V. K. / Vinesett, R. / Escolar, M. L. / Kurtzberg, J. et al. | 2007
- 68
-
185:Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot studyYamashiro, D. J. / Lee, A. / Bhatia, M. / Glade-Bender, J. / Qualter, E. / Militano, O. / Harrison, L. A. / Davenport, V. / Cheung, K. / Bradley, M. B. et al. | 2007
- 68
-
184:A novel RAG-1 null mutant displays segregation of DNA cleavage into transposition activity in three children with T-B-NK+SCIDXiao, T. Z. / Dunn, E. A. / Yannone, S. M. / Cowan, M. J. et al. | 2007
- 68
-
183:High-dose thiotepa, busulfan, and cyclophosphamide for allogeneic stem cell transplantion in risk pedaitric patients with high-risk leukemiasWorth, L. L. / Koontz, S. E. / Petropoulos, D. / Tran, H. T. / Choroszy, M. S. / Chan, K. et al. | 2007
- 69
-
186:Superior antitumor in vitro responses of allogeneic matched sibling compared to autologous patient CD8+ T cellsKausche, S. / Wehler, T. C. / Schnuerer, E. / Lennerz, V. / Groene, M. / Nonn, M. / Meyer, R. G. / Huber, C. / Herr, W. et al. | 2007
- 69
-
188:Stimulation of anti-tumor immunity using dendritic cell/tumor fusions and anti CD3/CD28Rosenblatt, J. / Wu, Z. / Lenahan, C. / Vasir, B. / Bisonette, A. / Kufe, D. / Avigan, D. et al. | 2007
- 69
-
187:In-vitro assessment of the effectiveness of busulfan (BU) to induce apoptosis and necrosis in neuroblastoma (NBL) cell lines and primary tumorsOlszewski, M. / Jackson, C. / Huang, W. / Tallman, S. / Kletzel, M. et al. | 2007
- 70
-
190:Semi-high-dose autologous and a non-myeloablative reduced intensity conditioning allogeneic transplants integrated in standard or dose dense therapy for breast cancer: Cost-efficiency analyses support design of cost-efficient therapiesVan Hoef, M. E. et al. | 2007
- 70
-
189:γδ T cells as immunotherapy for glioblastoma multiformeSuarez, C. / Bryant, N. L. / Gillespie, Y. / Lopez, R. D. / Markert, J. M. / Lamb, L. S. et al. | 2007
- 70
-
191:The role of human CYP2B6 polymorphism in the bioactivation of cyclophosphamide using cDNA expressed enzymesAfsharian, P. / Terelius, Y. / Hidestrand, M. / Ingelman-Sundberg, M. / Hassan, M. / Lundgren, S. et al. | 2007
- 71
-
192:TPO induces hematopoietic differentiation of human ES cellsSrivastava, A. S. / Nedelcu, E. / Mishra, R. / Carrier, E. et al. | 2007
- 71
-
193:Intestinal tissue engineering: A preliminary study of long term in vitro primary culture of intestinal epithelial cellsGandia, C. / David, A. / Santiago, S. / Ruiz, P. / Tzakis, A. / Kleiner, G. et al. | 2007
- 71
-
194:A molecular profile of endothelial cell-derived growth factors that regulate stem cell self-renewalHimburg, H. / Muramoto, G. G. / Salter, A. B. / Zhai, J. / Chi, J. T. / Chute, J. P. et al. | 2007
- 72
-
195:FLT3 expression discriminates HSC subpopulations with differing engraftment-potentialHuang, Y. / Ratajczak, M. Z. / Reca, R. / Xu, H. / Tanner, M. / Rezzoug, F. / Hussain, L. R. / Fugier-Vivier, I. / Bolli, R. / Ildstad, S. T. et al. | 2007
- 72
-
197:Mutated Hoxb4 results in increased intracellular stability affecting both long and short term hematopoietic reconstitutionBeauchemin, S. / Krosl, G. / Nathalie, B. / Krosl, J. / Sauvageau, G. / Roy, D. C. et al. | 2007
- 72
-
196:Ability of anti c-Kit targeting monoclonal antibody ACK-2 to target hematopoietic stem cells, and facilitate engraftment of human CD34+ engraftment and hematolymphoid development in immunodeficient mice: A novel antibody based conditioning strategyKraft, D. L. / Czechowicz, A. / Bhattacharya, D. / Weissman, I. L. et al. | 2007
- 73
-
Allogeneic Stem Cell Transplantation for Solid Tumors: Which Way Forward?Blaise, D. / Bregni, M. et al. | 2007
- 73
-
200:Cost analysis of allogenic peripheral blood transplantation: Impact of degree of mucositis and usage of paliferminDooley, M. J. / Schwarer, A. / Poole, S. G. / Radhakrishnan, M. / Farag, S. / Neville, M. / Lee, J. et al. | 2007
- 73
-
198:The use of recombinant human erythropoietin (rHuEpo) after reduced intensity conditioning (RIC) allogeneic hematopoietic peripheral blood stem cell transplantation (ASCT) reduces red blood cell (RBC) transfusion requirementsIvanov, V. / El Cheikh, J. / Faucher, C. / Furst, S. / Mohty, M. / Ladaique, P. / Lemarie, C. / Charbonnier, A. / Coso, D. / Schiano, J. M. et al. | 2007
- 73
-
199:Prospective oral mucositis audit (POMA): Occurrence and consequences of severe oral mucositis in high dose melphalan and beam conditioningBlijlevens, N. / McCann, S. / Bacon, P. / Quinn, B. / Schwenkglenks, M. / Stone, R. / Pico, J. et al. | 2007
- 74
-
Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with CidofovirNeofytos, D. / Ojha, A. / Mookerjee, B. / Wagner, J. / Filicko, J. / Ferber, A. / Dessain, S. / Grosso, D. / Brunner, J. / Flomenberg, N. et al. | 2007
- 74
-
202:Role of transfusion in stem cell transplantation: A freedom-from-transfusion (FFT), cost and survival analysisGanguly, S. / Bradley, J. P. / Skikne, B. S. / Divine, C. L. / Deauna-Limayo, D. / Bodensteiner, D. B. / Patel, J. S. et al. | 2007
- 74
-
201:Impact of palifermin on hospital resource consumption associated with allogenic peripheral blood transplantation and total body irradiationDooley, M. J. / Schwarer, A. / Radhakrishnan, M. / Poole, S. G. / Neville, M. A. / Jennifer, L. / Farag, S. et al. | 2007
- 75
-
205:An evaluation of infections and resistance patterns after implementation of antibiotic prophylaxis in neutropenic cancer patientsKennedy, L. D. / Gatesman, M. L. / High, K. / Karchmer, T. B. et al. | 2007
- 75
-
204:Prophylactic red blood cell exchange for prevention of severe hemolysis after minor ABO-incompatible stem cell transplantation following reduced-intensity conditioningWorel, N. / Mitterbauer, M. / Leitner, G. / Rabitsch, W. / Greinix, H. / Kalhs, P. / Hoecker, P. et al. | 2007
- 75
-
203:Vaccination against infection after haemopoietic stem cell transplant: A survey of practice in the UK & Ireland (British Society of Bone Marrow Transplantation)Gilleece, M. H. / Towlson, K. / Wilson, M. / Littlewood, T. / Cook, G. / Marks, D. I. et al. | 2007
- 76
-
208:Impact of posaconazole (POS) vs fluconazole (FLU) on cyclosporine (CsA) and tacrolimus (TAC) dosing in hematopoietic stem cell transplant (HSCT) recipients with graft-vs-host disease (GVHD)Langston, A. / Lipton, J. H. / Brundage, T. / Patino, H. / Ullmann, A. J. et al. | 2007
- 76
-
Graft Biology: Marrow Versus Peripheral Blood Versus Cord BloodChamplin, R. et al. | 2007
- 76
-
207:Sample size requirements for studies in which time-to-neutrophil-engraftment is the primary statistical endpointKlumpp, T. P. / Emmons, R. V. / Martin, M. E. / Gajewski, J. / Wirk, B. / Mangan, K. F. et al. | 2007
- 76
-
206:Effects of warming methods on temperature, cardiac function and immunologic function in plateletpheresis donorsKim, H. J. / Park, C. W. / Kim, N. C. et al. | 2007
- 76
-
Peripheral Blood Stem Cells Versus Bone Marrow for Ablative TransplantationEapen, M. et al. | 2007
- 77
-
211:The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)Nasilowska-Adamska, B. / Rzepecki, P. / Manko, J. / Czyz, A. / Markiewicz, M. / Fedorowicz, I. / Tomaszewska, A. / Piatkowska-Jakubas, B. / Wrzesien-Kus, A. / Bieniaszewska, M. et al. | 2007
- 77
-
209:Practice variation in supportive care in hematopoietic cell transplantationLee, S. J. / Eapen, M. / Soiffer, R. J. / McCarthy, P. L. / Loberiza, F. / Kernan, N. A. / Jagasia, M. / Davies, S. / Artz, A. / Joffe, S. et al. | 2007
- 77
-
210:Prevalence of falls and subsequent patterns of injury in a pediatric oncology hospitalMattox, S. / Dycus, P. / Hale, G. A. et al. | 2007
- 78
-
212:Adenovirus (ADV) infections following allogeneic stem cell transplant (alloSCT) in children and adolescent recepientsOesterheld, J. / George, D. / Bradley, B. / Del Toro, G. / Garvin, J. / Bhatia, M. / Satwani, P. / Roman, E. / Cooney, E. / Militano, O. et al. | 2007
- 78
-
213:Thrombotic complications: Etiology, treatment and outcome post-autologous and allogeneic hematopoeitic stem cell transplant. A single center experiencePeres, E. M. / Abidi2, M. / Ibrahim3, R. / Mellon-Reppen4, S. et al. | 2007
- 78
-
214:Cardiac complications in patients undergoing a reduced intensity conditioning allogeneic hematopoietic stem cell transplantation (HSCT): A single center experienceAbidi, M. H. / Ibrahim2, R. / Mellon-Reppen3, S. / Peres, E. et al. | 2007
- 78
-
Who Should Get Cord Blood Transplants?Barker, J. N. et al. | 2007
- 79
-
216:AMD 3100 successfully mobilizes autologous CD34+ cells after failure of G-CSF mobilization regimens with low toxicity and acceptable autologous stem cell transplant (ASCT) outcomesShaughnessy, P. J. / Hougham, M. / Bachier, C. / LeMaistre, C. F. et al. | 2007
- 79
-
217:Evaluation of single-dose palifermin to reduce mucositis: Assessment of efficacy and safety in patients (PTS) with hematologic malignancies (HM) receiving autologous peripheral blood progenitor cell (PBPC) transplantationShea, T. / Kewalramani, T. / Mun, Y. / Jayne, J. / Dreiling, L. et al. | 2007
- 79
-
215:Palifermin reduces the incidence of oral mucositis after ablative preparative regimens in patients undergoing an umbilical cord blood transplantRodriguez, T. E. / Toor, A. A. / Smith, S. E. / Parthasarathy, M. / Stiff, P. J. et al. | 2007
- 80
-
219:N-acetylcysteine administration for the prevention of the liver complications following allogeneic hematapoetic stem cell transplantationZook, J. / Trifilio, S. / Scheetz, M. / Pi, J. / Golf, M. / Mehta, J. et al. | 2007
- 80
-
218:Low dose ambisome anti-fungal prophylaxis in pediatric allogeneic unrelated hematopoietic stem cell transplantShinkle, M. / Carver, A. / Quinones, R. / Foreman, N. / Gore, L. / Peltz, A. / Christensen, M. / Wightman, C. / Kissane, R. / Malcolm, J. et al. | 2007
- 81
-
221:A submyeloablative regimen of Campath-1H and Fludarabine for patients with graft failure following allogeneic transplantation from MHC identical or near identical donorsAhmed, N. / Leung, K. S. / Bollard, C. M. / Gottschalk, S. / Myers, G. D. / Carrum2, G. / Heslop, H. E. / Brenner, M. K. / Krance, R. A. et al. | 2007
- 81
-
220:Role of lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in predicting relapse in pediatric acute leukimiasAfzal, S. / Ishaqi, M. K. / Dupius, A. / Doyle, J. / Gassas, A. et al. | 2007
- 81
-
222:The conditioning regimen intensity of allogeneic hematopoietic cell transplantation (allo-HCT) in chronic myeloid leukemia (CML): The historical case matched comparison of ablative versus reduced intensity regimenGurman, G. / Arat, M. / Topcuoglu, P. / Caglayan, E. A. / Arslan, O. / Ozcan, M. / Akan, H. / Beksac, M. / Konuk, N. / Uysal, A. et al. | 2007
- 82
-
Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in AdultsBallen, K. K. / Spitzer, T. R. / Yeap, B. Y. / McAfee, S. / Dey, B. R. / Attar, E. / Haspel, R. / Kao, G. / Liney, D. / Alyea, E. et al. | 2007
- 82
-
224:Thiotepa based conditioning regimen in 374 patients undergoing allogeneic stem cell transplants from related or unrelated donorsBacigalupo, A. / Gualandi, F. / Occhini, D. / Bregante, S. / Lamparelli, T. / Raiola, A. M. / Ibatici, A. / Di Grazia, C. / Dominietto, A. / Bruno, B. et al. | 2007
- 82
-
223:C-reactive protein (CRP) may predict transplant-related mortality after allogeneic hematopoietic cell transplant (HCT)Artz, A. S. / Wickrema, A. / Stock, W. / Daugherty, C. / Godley, L. / Kocherginsky, M. / Odenike, O. / Pollyea, D. / Rich, E. / Ulsazek, J. et al. | 2007
- 83
-
226:Differential requirement for NKG2D in the rejection of haplomismatched and MHC-I deficient bone marrowBenjamin, J. E. / Lanier, L. L. et al. | 2007
- 83
-
227:Determination of alemtuzumab dose for reduced intensity conditioning in allogeneic transplantationBigelow, C. L. / Elkins, S. L. / Herrin, V. E. / Hardy, C. L. / Files, J. C. et al. | 2007
- 83
-
Optimal Donor Selection: Beyond HLAConfer, D. L. / Miller, J. P. et al. | 2007
- 83
-
225:Kepivance use in allogeneic stem cell transplantationBayer, R. L. / Kim, B. / John, V. / Devoe, C. / Cannon, M. / Klocke, J. / Gissinger, D. et al. | 2007
- 83
-
228:Nonmyeloablative allogeneic stem cell transplantation (NST) for hematologic malignancies (HM) using pentostatin/low-dose total body irradiation (Pt-TBI)Bociek, R. G. / Talmadge, J. E. / Loberiza, F. / Kuszynski, C. A. / Bierman, P. J. / Vose, J. M. / Devetten, M. P. / Maness, L. J. / Armitage, J. O. / Joshi, S. et al. | 2007
- 84
-
229:Umbilical cord blood transplantation for adult patients with chronic myeloid leukemiaBrunstein, C. / Setubal, D. / DeFor, T. / Weisdorf, D. / McGlave, P. / Miller, J. / Wagner, J. et al. | 2007
- 84
-
230:Fludarabine/full dose I.V. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patientsChunduri, S. / Dobogai, L. C. / Peace, D. / Saunthararajah, Y. / Quigley, J. / Chen, Y. H. / Boccuni, P. / Hoffman, R. / Mahmud, N. / Beri, R. et al. | 2007
- 84
-
231:Haploidentical non-myeloablative hematopoietic transplant with sirolimus based immunosuppression yields reliable engraftment and may result in long term survivalClaxton, D. F. / Creme, L. / Ehmann, W. C. / Rybka, W. B. et al. | 2007
- 85
-
233:CD34 dose and chronic graft versus host disease (cGVHD) affect survival in allogeneic peripheral blood stem cell transplantation (alloPBSCT) following non-myeloablative (NM) conditioning: The Vanderbilt University/Nashville VA SCT program experienceEwing, G. / Giglia, J. / Vusirikala, M. / Ye, F. / Shyr, Y. / Chinratanalab, W. / Ruffner, K. / Kassim, A. / Jagasia, M. / Engelhardt, B. et al. | 2007
- 85
-
232:A critical role of CD100 in allogeneic immune responsesDuran-Struuck, R. / Lowler, K. / Beth, W. / Luker, G. / Liu, C. / Kumanogoh, A. / Reddy, P. / Ferrara, J. L. et al. | 2007
- 86
-
235:Hyperglycemia during neutropenia was associated with poor outcome in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)Fuji, S. / Kim, S. W. / Mori, S. I. / Fukuda, T. / Kamiya, S. / Yamasaki, S. / Tanosaki, R. / Tobinai, K. / Takaue, Y. et al. | 2007
- 86
-
234:Rapamycin generated donor Th2/Tc2 cells prevent graft rejection by inhibition of alloreactivity and not by deletion of alloreactive T cellsMariotti, J. / Foley, J. / Wong, E. / Borenstein, T. / Han, S. / Hanson, J. / Fowler, D. H. et al. | 2007
- 87
-
237:Long term results of allogeneic stem cell transplant for CML in pediatric patients: A study of 50 cases transplanted over 20 years in a single institutionFunke, V. A. / Pettengill, C. / Bonfim, C. M. / Ruiz, J. / Azambuja, A. P. / Medeiros, L. / Setubal, D. C. / Bitencourt, M. A. / Oliveira, M. M. / Coutinho, E. N. et al. | 2007
- 87
-
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current PerspectivesSandmaier, B. M. / Mackinnon, S. / Childs, R. W. et al. | 2007
- 87
-
236:Thrombotic microangiopathy after HSCT: Mucositis as a risk factor for survival and high prevalence of acute GVHD, CMV and gram positive infectionsFunke, V. A. / Oliveira, M. M. / Ruiz, J. / Bonfim, C. M. / Bitencourt, M. A. / Coutinho, E. N. / Setubal, D. C. / Zanis-Neto, J. / de Medeiros, C. P. / Pasquini, R. et al. | 2007
- 87
-
238:Risk factor analisis for survival in 125 unrelated transplants for malignant diseases performed over ten years in a single center in BrazilFunke, V. A. / Coutinho, E. N. / Setubal, D. C. / Ruiz, J. / Bonfim, C. M. / Bittencourt, M. A. / Oliveira, M. M. / Zanis-Neto, J. / de Medeiros, C. P. / Pasquini, R. et al. | 2007
- 88
-
239:Plateau in the disease-free survival curve after allogeneic stem cell transplantation in patients with acute myeloid leukemia may signify cure: A long-term single institution experienceGanguly, S. / Divine, C. L. / Deauna-Limayo, D. / Bodensteiner, D. C. / Lewis, J. L. / Hoffmann, T. / Curran, K. / Skikne, B. S. et al. | 2007
- 88
-
241:Neurological complications in the recipients of allogeneic hematopoietic cell transplantSiegal, D. / Keller, A. / Xu, W. / Bhuta, S. / Loach, D. / Kim, D. / Walia, J. / Kuruvilla, J. / Lipton, J. / Minden, M. et al. | 2007
- 88
-
240:Reduced-intensity stem cell transplantation in patients with high-risk acute lymphoblastic leukemia (ALL)Gutierrez-Aguirre, C. H. / Ruiz-Argü / elles, G. J. / Cantu-Rodriguez, O. G. / Gonzalez-LLano, O. / Gomez-Almaguer, D. et al. | 2007
- 89
-
242:Mixed chimerism (MC) after standard allo stem cell transplantation (SCT) in children: 1) can MC be used as a predictor of relapse? 2) when does MC become stable after transplant of non-malignant patients?Heilmann, C. / Madsen, H. O. / Muller, K. G. / Jacobsen, N. et al. | 2007
- 89
-
243:Impact of 100-day survival on long-term outcome of myeloablative transplant at an early stage of leukemiaHiraoka, A. et al. | 2007
- 90
-
246:Allogeneic blood and marrow transplantation in thalassemia major class 3: An experience of IranIravani, M. / Ali Mogaddam, K. / Nedaeifard, L. / Khatami, F. / Gavamzadeh, A. / Golibeygian, S. / Bab Hadiashar, N. / Jalili, M. / Tagipur, R. / Gaffari, F. et al. | 2007
- 90
-
Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus-I–negative Donors for Adult T-Cell Leukemia/Lymphoma: Retrospective Analysis of Data from the Japan Marrow Donor ProgramKato, K. / Kanda, Y. / Eto, T. / Muta, T. / Gondo, H. / Taniguchi, S. / Shibuya, T. / Utsunomiya, A. / Kawase, T. / Kato, S. et al. | 2007
- 90
-
244:Fludarabine-based non-myeloablative stem cell transplantation in a patient with sickle cell disease and renal failure: Clinical outcome and pharmacokinetic comparison to patients with normal renal functionSpasojevic, I. / Morris, A. / Long, G. / Gasparetto, C. / Sullivan, K. / Chute, J. / Telen, M. / Chao, N. / Rizzieri, D. / Horwitz, M. et al. | 2007
- 90
-
245:Donor killer Ig-like receptor haplotype is associated with lower relapse in chronic myelogenous leukemia patients undergoing allogeneic hematopoietic cell transplantationAbarghoui, F. / Pinto-Agnello, C. / Gooley, T. / Senitzer, D. / Malkki, M. / Dupont, B. / Petersdorf, E. / Hsu, K. et al. | 2007
- 91
-
249:A mind and physical fitness program in cancer care – Feasibility of a multimodal exercise and psycho-educational intervention for patients undergoing allogeneic stem cell transplantation. A randomized controlled pilot studyJarden, M. / Hovgaard, D. / Boesen, E. / Adamsen, L. et al. | 2007
- 91
-
247:Outcome of allogeneic hematopoietic stem cell transplantation for children with acute myelogenous leukemia in second complete remission, single centre experienceIshaqi, M. K. / Afzal, S. / Doyle, J. / Gassas, A. et al. | 2007
- 91
-
248:Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic stem cell transplantation (ASCT) in patients with chronic myeloid leukemia (CML): No evidence for increased transplant-related toxicityJabbour, E. / Cortes, J. / Kantarjian, H. / Giralt, S. / Champlin, R. / de Lima, M. et al. | 2007
- 92
-
252:Outcome of allogeneic hematopoietic stem cell transplantation for pediatric patients with chronic myeloid leukemiaKennedy-Nasser, A. A. / Arce, J. / Leung, K. S. / Gottschalk, S. / Bollard, C. M. / Heslop, H. E. / Brenner, M. K. / Krance, R. A. et al. | 2007
- 92
-
250:Co-stimulatory molecule expression by transplanted donor APC and host CD4 T cells is required to elicit resistance against MHC-matched hematopoietic allografts following reduced intensity conditioningJones, M. / Blazar, B. P. / Zimmerman, Z. / Levy, R. B. et al. | 2007
- 92
-
251:Low rates of chimerism occur when alemtuzumab is added to conditioning therapy for non-myeloablative allogeneic stem cell transplantationKasner, M. / Loren, A. / Stein, S. / Goldstein, S. / Luger, S. / Nasta, S. / Perl, A. / Schuster, S. / Tsai, D. / Andreadis, B. et al. | 2007
- 93
-
255:Correlation between infused mononuclear cells (MNC) and transplant outcome in pediatric cord blood transplantation (CBT). A study of 92 single CBT done at Children’s Memorial Hospital, Chicago, ILMerchant, M. / Olszewski, M. / Huang, W. / Duerst, R. / Jacobsohn, D. / Kletzel, M. et al. | 2007
- 93
-
253:Assessment of adenovirus subgenera prevalence by real-time PCR in immunocompromised patientsDuncan, K. / Reddy, S. / Vats, A. / Kleiboeker, S. et al. | 2007
- 93
-
254:Successful HSCT after multivisceral transplantationKleiner, G. I. / Gonzalez-Brito, M. / Weppler, D. / White, E. / Simon, N. / David, A. / Selvaggi, G. / Kato, T. / Shariatmadar, S. / Tzakis, A. et al. | 2007
- 94
-
256:Hematopoietic stem cell transplantation for hematological diseases at Yeditepe University HospitalYirmibescik, S. / Senkal, V. / Kalayci, G. / Aktas, S. / Aydin, D. / Sonmezoglu, M. / Kocagoz, S. / Oyan, B. / Koc, Y. et al. | 2007
- 94
-
258:Syngeneic stem cell transplantation for aplastic anemia in an HIV+ patientLongoni, H. O. / Binaghi, M. A. / Kohan, A. I. / Lasala, M. B. / Banchieri, A. V. / Minissale, C. J. / Plana, J. L. / Velicche, A. F. / Christin, M. P. / Corach, D. et al. | 2007
- 94
-
257:Validation of the hematopoietic cell transplantation-comorbidity index (HCT-CI) for non-relapse mortality (NRM) and survival after matched unrelated donor SCTKovacsovics, T. / Hayes-Lattin, B. / Riegert, K. / Subbiah, N. / Curtin, P. T. / Leis, J. F. / Mauro, M. M. / Epner, E. E. / Fleming, W. H. / Meyers, G. M. et al. | 2007
- 95
-
261:Characteristics of two conditioning regimens cyclophosphamide plus antithymocyte globulin versus cyclophosphamide plus busulfan in allogeneic stem cell transplantation for severe aplastic anemiaOmmati, L. V. / Silva, A. P. / Silva, L. P. / Faria, J. R. / Chaufaille, M. d. / Oliveira, J. S. et al. | 2007
- 95
-
260:An improved method for engraftment monitoring using Real-time PCRMcLaughlin, I. J. / Bost, D. A. / Mountain, J. L. / McGinnis, M. D. / Krausa, P. et al. | 2007
- 95
-
259:Absolute chimerism as a tool in monitoring imminent and manifest graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioningMasmas, T. N. / Petersen, S. L. / Madsen, H. O. / Ryder, L. P. / Svejgaard, A. / Andersen, P. / Dickmeiss, E. / Vindelov, L. L. et al. | 2007
- 96
-
264:Influence of interleukin-6 (IL-6) gene polymorphism on the outcome of patients undergoing allogeneic stem cell transplantationRaida, L. / Faber, E. / Mrazek, F. / Indrak, K. / Petrek, M. / Zapletalova3, J. / Ambruzova, Z. / Kriegova, E. / Onderkova, J. et al. | 2007
- 96
-
263:Non-myeloablative conditioning therapy with fludarabine, cyclophosphamide and ATG allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donor in patients with severe aplasic anemia (SAA)Pawlowska, A. / Bolotin, E. / Falk, P. / Forman, S. / LaBossiere, D. / Rosenthal, J. et al. | 2007
- 96
-
262:Early expansion of lymphoid cells precedes myeloid engraftment following hematopoietic cell transplantation using truly nonmyeloablative cyclophosphamide/fludarabine conditioningPandurangadu, A. V. / Nelson, R. P. et al. | 2007
- 97
-
265:Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantationRemberger, M. / Watz, E. / Ringdé / n, O. / Mattsson, J. / Shanwell, A. / Wikman, A. et al. | 2007
- 97
-
268:Umbilical cord blood transplantation using non-myeloablative conditioning: The Mexican experienceMancias-Guerra, C. / Ruiz-Delgado, G. J. / Manzano, C. / Diaz-Hernandez, M. A. / Tarin-Arzaga, L. C. / Gonzalez-Llano, O. / Calderon, E. D. / Gomez-Almaguer, D. / Ruiz-Arguelles, G. J. et al. | 2007
- 97
-
266:Fludarabine – oral busulfan myeloablative conditioning for allogenic peripheral stem cell transplantation. A single center experience in ColombiaRosales, C. / Abello, V. / Rosales, E. / Esguerra, H. / Linares, A. et al. | 2007
- 97
-
267:Reduced risk of relapse in pediatric patients after double unit cord blood transplantation? A single institution experienceRosenthal, J. / Bolotin, E. / Pawlowska, A. / Falk, P. / Hitt, D. / Forman, S. et al. | 2007
- 98
-
Measures of Morbidity: Functional Assessment and CytokinesGiralt, S. / Simmonds, M. / Smith, R. et al. | 2007
- 98
-
269:Correlates and outcome of absolute lymphocyte count (ALC) on day 30 post allogeneic stem cell transplantation (SCT) for treatment of AMLSaliba, R. M. / Komanduri, K. / Giralt, S. / de Souza, J. / Patah, P. A. / Oran, B. / Rondon, G. / Couriel, D. P. / Champlin, R. / de Lima, M. et al. | 2007
- 98
-
270:Allogeneic hematopietic cell transplantation in myelofibrosis with myeloid metaplasia – lessons from single center resultsBaurmann, H. / Collenbusch, F. / Thiede, C. / Burlakova, I. / Schleuning, M. / Schwerdtfeger, R. et al. | 2007
- 99
-
271:Umbilical cord blood transplantation – report of 106 cases from a single Brazilian institutionSetubal, D. C. / Medeiros, C. P. / Bitencourt, M. A. / Bonfim, C. M. / Funke, V. A. / Zanis, J. / Cesario, E. / Carvalho, D. / Nunes, E. / Oliveira, M. M. et al. | 2007
- 99
-
273:Safety and efficacy of high-dose busulfan by 90-hour continuous infusion in hematologic malignancy patients undergoing allogeneic stem cell transplantsShea, T. / Walko, C. / Serody, J. / Gabriel, D. / Comeau, T. / Rao, K. / Ivanova, A. / Sharf, A. / Krasnov, C. / Coghill, A. et al. | 2007
- 99
-
272:Demonstration of a single MiHA specificity recognized by memory CD8 T cells which induces resistance to MHC-matched hematopoietic allograftsShatry, A. M. / Levy, R. B. et al. | 2007
- 100
-
274:Treosulfan: An attractive alternative in the conditioning in bone marrow transplant for thalassemiaSmiers, F. J. / Bredius, R. / Ball, L. / Lankester, A. / Bakker, H. / Egeler, R. M. et al. | 2007
- 100
-
275:Impacts of comorbidities on outcomes of patients (pts) younger than 60 years old, diagnosed with indolent malignancies and treated with allogeneic hematopoietic cell transplantation (HCT): A model for pts with autoimmune diseasesSorror, M. L. / Storb, R. / Storer, B. / Maloney, D. G. / Sandmaier, B. M. et al. | 2007
- 100
-
276:Outcome of patients according to ethnic groups receiving allogeneic stem cell transplantation in MalaysiaTan, S. M. / Chang, K. M. / Ong, T. C. / Salleh, S. / Sathar, J. / Purushothaman, V. et al. | 2007
- 100
-
277:Allogeneic hematopoietic cell transplantation in imatinib era: A single center comparative analysis of imatinib receiving patients to imatinib naive patientsUgur Bilgin, A. / Soydan, E. / Topcuoglu, P. / Arslan, O. / Ozcan, M. / Gurman, G. / Demirer, T. / Akan, H. / Beksac, M. / Konuk, N. et al. | 2007
- 100
-
Risk Factors for Developing Human Herpesvirus 6 (HHV-6) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation and Its Association with Central Nervous System DisordersYamane, A. / Mori, T. / Suzuki, S. / Mihara, A. / Yamazaki, R. / Aisa, Y. / Nakazato, T. / Shimizu, T. / Ikeda, Y. / Okamoto, S. et al. | 2007
- 101
-
279:CD154:CD40 co-stimulatory blockade at primary BMT promotes allogeneic engraftment in secondary BMT by blocking sensitizationXu, H. / Huang, Y. / Hussain, L. R. / Yan, J. / Ildstad, S. T. et al. | 2007
- 101
-
278:Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantationVu, T. / Kamble, R. / Oholendt, M. / Scholoff, A. / Obi, G. / East, K. / Hutton, G. / Heslop, H. / Brenner, M. / Carrum, G. et al. | 2007
- 102
-
282:Human Tregs induced by ECDI-coupled APC for the suppression of transplantation alloresponsesAlbert, M. H. / Magg, T. et al. | 2007
- 102
-
281:Alteration of NK tolerance early post-allogeneic hematopoietic cell transplantation results in NK alloreactivity driven by lack of recipient HLA ligand for donor inhibitory KIRYu, J. / Chewning, J. / Hsu, K. et al. | 2007
- 102
-
280:The impact of early onset of hemophagocytosis after transplantation on the outcome of allogenic stem cell transplantationYasuda, T. / Ito, M. / Imahashi, N. / Nisiwaki, S. / Yanagisawa, M. / Takahashi, T. / Kuwatuka, Y. / Oba, T. / Miyamura, K. / Kodera, Y. et al. | 2007
- 103
-
283:Rituximab infusion two months after total lymphoid irradiation-antithymocyte globulin (TLI-ATG) nonmyeloablative transplantation maintains B-cell disease control with minimal GVHDArai, S. / Sahaf, B. / Jones, C. / Zehnder, J. / Lowsky, R. / Strober, S. / Shizuru, J. / Negrin, R. / Johnston, L. / Laport, G. et al. | 2007
- 103
-
284:CDR3 size spectratype analysis of patients with chronic graft-versus host disease reveals complexity of the T cell repertoireAzhipa, O. Y. / Rowley, S. D. / Donato, M. L. / Korngold, R. / Friedman, T. M. et al. | 2007
- 103
-
Radiation Emergencies: Evaluation, Management, and TransplantationWeisdorf, D. / Apperley, J. / Courmelon, P. / Gorin, N. C. / Wingard, J. / Chao, N. et al. | 2007
- 104
-
286:Role of respiratory viral infection in the development of allo-reactive lung diseaseVersluys, B. / Rossen, J. / Bierings, M. / Schuurman, R. / van Ewijk, B. / Boelens, J. J. et al. | 2007
- 104
-
287:Reduced intensity conditioning allografting induces the generation of antigen-specific regulatory T cells necessary for graft toleranceWeng, L. / Dyson, J. / Dazzi, F. et al. | 2007
- 104
-
285:Manifestations of acute and chronic graft-versus-host-disease in reduced-intensity allogeneic stem cell transplantation (RISCT) for pediatric cancerBaird, K. / Fry, T. J. / Love, C. / Layton, P. / Rager, A. / Cordoza-Salzman, T. / Mackall, C. L. / Wayne, A. S. et al. | 2007
- 105
-
290:Rapamycin-generated Th2 cell therapy of established acute murine GVHD requires Th2 cell secretion of both IL-4 and IL-10Foley, J. E. / Mariotti, J. / Borenstein, T. / Han, S. / Eckhaus, M. / Fowler, D. et al. | 2007
- 105
-
288:A small molecular weight antagonist of CXCR3 reduces the severity of experimental idiopathic pneumonia syndrome and improves survival following allogeneic stem cell transplantationDeurloo, D. T. / Chaudhary, M. N. / Olkiewicz, K. M. / Silva, I. A. / Choi, S. W. / Liu, C. / Collins, T. L. / Sullivan, T. J. / Cooke, K. R. et al. | 2007
- 105
-
289:The use of CDR3 Vβ spectratype analysis to identify GVHD and GVL-reactive CD8+ T cell responses in a myeloid leukemia challenged minor H antigen mismatched mouse transplantation modelFanning, S. L. / Gichuru, L. N. / Korngold, R. / Friedman, T. M. et al. | 2007
- 106
-
291:Novel approach for predicting GVHD reactive T cells using Vβ spectratype analysis of dividing CFSE-labeled T cells from a mixed lymphocyte reactionZilberberg, J. / Fanning, S. L. / Friedman, T. M. / Korngold, R. et al. | 2007
- 106
-
293:Risk factors associated with chronic GVHD revisited: A study of 142 patients with malignant diseases transplanted in a single center in BrazilFunke, V. A. / Medeiros, L. / Coutinho, E. N. / Pettengil, C. / Ruiz, J. / Oliveira, M. M. / Setubal, D. C. / Bonfim, C. M. / Bitencourt, M. A. / Zanis-Neto, J. et al. | 2007
- 106
-
292:Dendritic cell vaccination expands antigen specific T cells following allogeneic transplantationHerby, S. / Davis, J. / Wayne, A. S. / Fry, T. J. et al. | 2007
- 106
-
294:Alemtuzumab in the treatment of steroid refractory acute graft-versus-host diseaseGomez-Almaguer, D. / Ruiz-Arguelles, G. / Gonzalez-Llano, O. / Gutierrez, C. / Jaime-Perez, J. C. / Tarin-Arzaga, L. / Giralt, S. et al. | 2007
- 107
-
Facing the Next Pandemic: Ready or NotWingard, J. R. et al. | 2007
- 107
-
295:Graft versus host disease after stem cell allotransplantation with low dose TBI, fludarabine and ATGGrosskreutz, C. L. / Scigliano, E. / Osman, K. / Isola, L. M. et al. | 2007
- 107
-
296:Etanercept as salvage therapy for chronic graft-versus-host diseaseGulbis, A. M. / Hsu, Y. / Neumann, J. L. / Hymes, S. / de Lima, M. J. / Hosing, C. M. / Khouri, I. F. / Qazilbash, M. H. / Kebriaei, P. / Andersson, B. S. et al. | 2007
- 107
-
Allogeneic Stem Cell Transplantation with T Cell-Depleted Grafts for Lymphoproliferative MalignanciesNovitzky, N. / Thomas, V. et al. | 2007
- 108
-
299:The role of SNPs within receptors of innate immunity in outcome following allogeneic stem cell transplantation: Synergism between TLR5-stop and NOD2/CARD15?Holler, E. / Krueger, B. / Rogler, G. / Brenmoehl, J. / Dickinson, A. M. / Greinix, H. / Wolff, D. / Finke, J. / Hahn, J. / Kraemer, B. et al. | 2007
- 108
-
297:Establishment of a chimeric NOD-scid/IL2RγcNull transplantation-model to evaluate graft-vs-host and graft-vs-leukemia immune responses of ex vivo modified human T lymphocyte graftsNonn, M. / Khan, S. A. / Shultz, L. D. / Handgretinger, R. / Hagemann, M. / Wehler, T. / Meyer, R. G. / Huber, C. / Herr, W. / Hartwig, U. et al. | 2007
- 108
-
298:Alloantigens expression on host non-hematopoietic cells leads to donor T cell exhaustion and reduces GVL effectsHashimoto, D. / Asakura, S. / Matsuoka, K. I. / Sakoda, Y. / Koyama, M. / Aoyama, K. / Tanimoto, M. / Teshima, T. et al. | 2007
- 109
-
302:Treatment of severe ocular surface disease from ocular chronic graft-versus-host disease with a scleral len prosthetic deviceJacobs, D. S. / Rosenthal, P. et al. | 2007
- 109
-
301:Selective expansion of human regulatory (CD4+CD25+CD127LowFOXP3+) cells to high purity by inhibiting expansion of CD4+CD25+CD127HighFOXP3- conventional T cells with rapamycinHou, J. Z. / Zambricki, E. / Zeiser, R. / Negrin, R. S. et al. | 2007
- 109
-
300:Immature dendritic cells downregulate graft versus host reactions in the human skin explant model after co-culture with in vitro PUVA treated lymphocytesHoltick, U. / Marshall, S. P. / Hilkens, C. M. / Wang, X. N. / Dickinson, A. M. et al. | 2007
- 110
-
New Technologies to Visualize T Cell Function: A Picture Tells a Thousand WordsBarrett, J. et al. | 2007
- 110
-
304:Rituximab responsive refractory acute graft versus host diseaseKamble, R. / Phalak, K. / Carrum, G. / Oholendt, M. / Heslop, H. / Brenner, M. et al. | 2007
- 110
-
303:Incidence and outcome of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplant (SCT) using National Institute of Health (NIH) consensus criteriaJagasia, M. / Chinratanalab, W. / Giglia, J. / Dixon, S. / Chen, H. / Frangoul, H. / Engelhardt, B. / Goodman, S. / Greer, J. / Kassim, A. et al. | 2007
- 111
-
306:Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)Kebriaei, P. / Isola, L. / Bahceci, E. / Holland, H. K. / Rowley, S. / McGuirk, J. / Devetten, M. / Jansen, J. / Herzig, R. / Schuster, M. et al. | 2007
- 111
-
Watching Immune Cells in ActionHuang, A. Y. et al. | 2007
- 111
-
307:Initial selection of high affinity CD25+ cells increases the purity of CD4+CD25+Foxp3+ T regulatory cells expanded in medium containing rapamycinKeever-Taylor, C. A. / Tsao, A. / Davies, B. et al. | 2007
- 111
-
305:Irradiation of cellular blood components with cobalt 60 is very efficient and safe in the prevention of transfusion associated graft versus host disease (TA-GVHD) in the allogeneic transplant settingKarduss, A. / Leon, E. / Buitrago, L. / Gomez, L. P. / Jimenez, J. A. / Reyes, P. / Coll, Y. et al. | 2007
- 112
-
309:Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantationWang, Y. / Li, D. / Jones, D. / Bassett, R. / Sale, G. E. / Khalili, J. / Komanduri, K. V. / Couriel, D. P. / Champlin, R. E. / Molldrem, J. J. et al. | 2007
- 112
-
308:Treatment of steroid refractory, severe acute graft versus host disease with expanded mesenchymal stem cells in children having undergone allogeneic stem cell transplantation: A single center experienceBall, L. M. / Kollen, W. J. / Lankester, A. / Roleofs, H. / Fibbe, W. E. / Egeler, R. M. et al. | 2007
- 113
-
310:Expression of STAT1 during graft-versus-host disease (GVHD)Ziegler, J. A. / Lokshin, A. / Bedeir, A. / Sepulveda, A. / Lentzsch, S. / Mapara, M. Y. et al. | 2007
- 113
-
311:The predictive value of gene expression profiles for acute graft-versus-host disease after hematopoietic cell transplantation with nonmyeloablative conditioning for hematological malignancyMasmas, T. N. / Friis-Hansen, L. / Petersen, S. L. / Schjerling, C. K. / Hansen, F. C. / Vindelov, L. L. et al. | 2007
- 113
-
312:Dendritic cell type 2 counts on day 28 in HLA-matched related allogeneic PBSCT predicts the incidence of acute and chronic GVHDRajasekar, R. / Mathews, V. / Lakshmi, K. M. / Viswabandya, A. / George, B. / Chandy, M. / Srivastava, A. et al. | 2007
- 114
-
315:Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipientsMilitano, O. / Hedgpeth, D. / Shaw, L. M. / Figurski, M. / Satwani, P. / Ayello, J. / Roman, E. / Bradley, B. / George, D. / Garvn, J. et al. | 2007
- 114
-
313:A cDNA-based assay for donor-chimerism analysis of epidermal langerhans cellsBakhtiar, S. / Bender, K. / Schmitt, T. / Moench, C. / Konur, A. / Huber, C. / Herr, W. / Meyer, R. G. et al. | 2007
- 114
-
314:Selective depletion of alloreacting T cells by TH9402-based photodepletion as a translational strategy for GVHD control in HLA-mismatched and matched donor-recipient pairsMielke, S. / Nunes, R. / Rezvani, K. / Fellowes, V. S. / Fan, Y. / Scotto, C. / Solomon, S. P. / Read, E. J. / Barrett, A. J. et al. | 2007
- 115
-
316:Characteristics of chronic graft-versus-host disease in Brazilian recipients of allogeneic stem cell transplants: A five-year retrospective analysisBouzas, L. F. / Moreira, M. C. / Tavares, R. d. / Lerner, D. / Azevedo, A. M. / Mattos, M. / Horn, P. / Collares, M. / Mellin, S. et al. | 2007
- 115
-
318:Extracorporeal photopheresis (ECP) for the treatment of steroid-refractory or -intolerant chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (HSCT)Pawarode, A. / Hahn, T. / Battiwalla, M. / McCarthy, P. L. et al. | 2007
- 115
-
317:Pre-transplant biomarkers predict GVHD and treatment-related mortality in patients treated with extracorporeal photopheresis prior to allogeneic bone marrow transplantationO’ / Brien, P. J. / Bolwell, B. / Abhyankar, S. / Shaughnessy, P. / Williamson, P. / Campbell, K. A. et al. | 2007
- 115
-
Visualizing the Immune SynapseKupfer, A. et al. | 2007
- 116
-
319:Interaction between host natural killer T cells and donor CD4+CD25+ Treg cells protects against GVHD after TLI/ATS host conditioning and allogeneic bone marrow transplantationPillai, A. B. / Dutt, S. / George, T. I. / Strober, S. A. et al. | 2007
- 116
-
Treatment of Relapsed Acute Leukemia after Allogeneic Transplantation: A Single Center ExperienceArellano, M. L. / Langston, A. / Winton, E. / Flowers, C. R. / Waller, E. K. et al. | 2007
- 116
-
320:In vivo activation of APCs with TLR ligands and tissue damage rather than amount of host APCs are critical factors that determine DLI-mediated GVL reactivity and GVHD in MHC-matched minor histocompatibility antigen (mHAg)-mismatched chimerasRadojcic, V. / Skarica, M. / Murphy, G. F. / Luznik, L. et al. | 2007
- 117
-
322:In vivo bioluminescence and [18F]-FHBG micropet imaging studies of human T cell trafficking, expansion, and xenogeneic graft-versus-host-disease following different routes of human T cell administrationRettig, M. P. / Nervi, B. / Ritchey, J. K. / Prior, J. L. / Piwnica-Worms, D. / Wang, H. L. / Bauer, G. / Walker, J. / Bonyhadi, M. L. / Berenson, R. J. et al. | 2007
- 117
-
323:Day 30 post-transplant absolute lymphocyte and natural killer cell count strongly predict outcome after allogeneic stem cell transplantation for hematological malignancySavani, B. N. / Mielke, S. / Rezvani, K. / Yong, A. / Shenoy, A. / Read, E. J. / Hensel, N. / Childs, R. / Barrett, A. J. et al. | 2007
- 117
-
321:Successful therapy of steroid-refractory acute graft-versus host disease with sequential alemtuzumabRepp, R. / Claviez, A. / Schrauder, A. / Schub, N. / Gahn, B. / Gramatzki, M. et al. | 2007
- 118
-
325:Mutant inosine monophosphate dehydrogenase II provides selective advantage to transduced cell lines above wild typeSchroeder, M. A. / Rettig, M. P. / Ritchey, J. K. / DiPersio, J. F. et al. | 2007
- 118
-
324:Treatment of steroid-resistant graft-versus-host disease with monoclonal antibodies in childrenSchechter, T. / Afzal, S. / Finkelstein, Y. / Koren, G. / Doyle, J. / Dupuis, L. L. et al. | 2007
- 118
-
326:Donor C3435T polymorphism in the multidrug resistance 1 (MDR1) gene is associated with the incidence of acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem-cell transplantation (alloSCT)Shimoni, A. / Ostrovsky, O. / Galski, H. / Hardan, I. / Shem-Tov, N. / Yerushalmi, R. / Nagler, A. et al. | 2007
- 119
-
327:Influence of killer immunoglobulin-like receptor (KIR) matching on the development of chronic graft-vs.-host disease (cGVHD) in T-cell depleted matched unrelated donor (MUD) allogeneic bone marrow transplantation (alloBMT)Sobecks, R. / Askar, M. / Ball, E. / Rybicki, L. / Thomas, D. / Bates, J. / Kalaycio, M. / Andresen, S. / Pohlman, B. / Dean, R. et al. | 2007
- 119
-
329:VB TCR usage and Treg CD4+CD25+CTLA4+/- cells in acute and chronic graft versus host disease, (GVHD), patients submitted to extracorporealphototherapy, (ECP): A study to evaluate their predictive significance on the GVHD outcomeTassi, C. / Arpinati, M. / Tazzari, P. L. / Ricci, F. / Conte, R. et al. | 2007
- 119
-
328:Changes in lymphocytes and regulatory T cells in chronic GVHDTabellini, L. / Haeusermann, P. / Flower, M. E. / Grogan, B. M. / Bumgarner, T. E. / Damodaran, A. C. / Martin, P. J. / Hansen, J. A. et al. | 2007
- 120
-
Visualizing Inside the CellNolan, G. et al. | 2007
- 120
-
330:Carcinoembryonic antigen related cell adhesion molecule 1 is an important suppressor of intestinal and systemic acute graft-versus-host-diseasevan den Brink, M. R. / Willis, L. / Bautista, J. / Chow, M. / Smith, O. M. / Cabrera-Perez, J. / Suh, D. / King, C. / Zakrzewski, J. / Kochman, A. et al. | 2007
- 120
-
331:Global assessment of B cell alloimmunity using microarrays of 5000 human proteinsWadia, P. P. / Coram, M. / Weintraub, L. / Butte, A. / Miklos, D. et al. | 2007
- 120
-
332:Effective graft-versus-leukemia responses are associated with the presence of nucleic acid-immunoglobulin complexes that stimulate toll-like receptors (TLR) 8 and 9Lin, Y. / Means, T. / Alyea, E. P. / Canning, C. M. / Soiffer, R. J. / Ritz, J. / Wu, C. J. et al. | 2007
- 121
-
333:Cytotoxic T lymphocyte responses to PR1 peptide in CML patients inversely correlate with proteinase 3 and elastase expression but donor PR1-responses determine molecular remission and disease eradication after stem cell transplantationYong, A. S. / Rezvani, K. / Savani, B. N. / Eniafe, R. / Mielke, S. / Goldman, J. M. / Barrett, J. et al. | 2007
- 121
-
335:Inhibition of HMG-CoA reductase activity with statins provides acute-graft-versus-host disease protection by Th-2 cytokine induction while sparing graft-versus-leukemia activityZeiser, R. / Youssef, S. / Baker, J. / Steinman, L. / Negrin, R. et al. | 2007
- 121
-
334:Cd18 separates GVHD and GVL effectLiang, Y. / Anasetti, C. / Yu, X. Z. et al. | 2007
- 122
-
336:Outcomes of double cord blood transplantation (DCBT) in a diverse populationBallen, K. / Nademanee, A. / Graham, M. / Jaing, T. H. / Tan, P. / Eames, G. / Rosenthal, J. / Karanes, C. / Gjertson, D. / Wang, B. et al. | 2007
- 122
-
338:Effect of CD3+ cell dose on outcome in patients after conditioning including antithymocyte globulin followed by un-manipulated HLA-mismatched/haploidentical blood and marrow transplantationDong, L. / Wu, T. / Lu, D. P. / Zhang, M. J. / Chen, H. / Gao, Z. Y. / Han, W. / Zhang, Y. C. / Wang, J. B. / Liu, Y. R. et al. | 2007
- 122
-
337:Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxisCutler, C. / Haspel, R. / Kao, G. / Ho, V. / Alyea, E. / Koreth, J. / Dey, B. / Spitzer, T. / Soiffer, R. J. / Antin, J. H. et al. | 2007
- 123
-
339:HLA-DRB1 allele and DRB1-DQB1 haplotype frequency as prediction criterion for the duration of an unrelated blood stem cell donor searchMytilineos, J. / Hirv, K. et al. | 2007
- 123
-
340:Unrelated cord blood transplantation after myeloablative conditioning in adult patients with acute myeloid leukemia not in remissionOoi, J. / Takahashi, S. / Tomonari, A. / Tojo, A. / Asano, S. et al. | 2007
- 123
-
341:Reduced-intensity allogeneic umbilical cord blood transplantation (RI-UCBT) in pediatric recipients with malignant and non-malignant diseasesSatwani, P. / Bradley, M. B. / Baldinger, L. / Morris, E. / van de Ven, C. / Garvin, J. / George, D. / Roman, E. / Baxer-Lowe, L. A. / Schwartz, J. et al. | 2007
- 124
-
343:Outcomes of unrelated donor hematopoietic stem cell transplantations for pediatric patients in ThailandVanichsetakul, P. / Wattanapaiboon, P. / Seksarn, P. / O-Charoen, R. / Kupatawintu, P. et al. | 2007
- 124
-
Errata| 2007
- 124
-
342:GVHD prophylaxis with tacrolimus offers low early mortality and better survival after reduced-intensity cord blood transplantation in elderly patients (≥55 years)Uchida, N. / Wake, A. / Takagi, S. / Yamamoto, H. / Kato, D. / Matsuhashi, Y. / Seo, S. / Matsuno, N. / Masuoka, K. / Yoneyama, A. et al. | 2007
- 125
-
344:Effects of preparative regimens on host dendritic cells pre-transplant in allogeneic stem cell transplantationChan, G. W. / Betancur, M. / Sprague, K. A. / Klein, A. K. et al. | 2007
- 125
-
ASBMT News| 2007
- 125
-
346:KIR2DS1 and 2DS2 induce NK cell cytokine response against allogeneic B-lymphoblastoid cell linesChewning, J. H. / Gudme, C. N. / Selvakumar, A. / Dupont, B. et al. | 2007
- 125
-
345:Radioprotection by growth hormoneChen, B. J. / Deoliveira, D. / Chao, N. J. et al. | 2007
- 126
-
348:Chronic GvHD decreases anti-CMV immune responses in allogeneic BMT: Defect in T-cell homingHossain, M. S. / Roback, J. D. / Pollack, B. P. / Jaye, D. L. / Waller, E. K. et al. | 2007
- 126
-
347:Intentional induction of mixed hematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukemia patientsPerez, A. / Gonzalez, M. / Ramirez, M. / Sevilla, J. / Diaz, M. A. et al. | 2007
- 126
-
349:Higher-order cytokine flow cytometry reveals distinct functional signatures of maturation subsets of CD4+ and CD8+ T cellsKim, T. K. / St. John, L. S. / Wieder, E. D. / Molldrem, J. J. / Komanduri, K. V. et al. | 2007
- 127
-
352:Clinical efficacy of cryopreserved donor lymphocytes for infusion (DLI)Lane, T. A. / Medina, B. / Bashey, A. / Holman, P. / Carrier, E. / Castro, J. / Ball, E. D. et al. | 2007
- 127
-
350:Clinical efficacy of long-term low dose acyclovir for VZV infection prophylaxis after allogeneic peripheral blood stem cell transplantationKim, D. H. / Messner, H. A. / Gupta, V. / Kuruvilla, J. / Chae, Y. S. / Sohn, S. K. / Lipton, J. H. et al. | 2007
- 127
-
351:Early recovery of host T cells predicts primary graft rejection following non-myeloablative conditioning allogeneic hematopoietic stem cell transplantationKoyama, M. / Hashimoto, D. / Kamezaki, K. / Numata, A. / Sakoda, Y. / Aoyama, K. / Takenaka, K. / Miyamoto, T. / Harada, N. / Nagafuji, K. et al. | 2007
- 127
-
New Directions in the Genomics of Allogeneic Hematopoietic Stem Cell TransplantationMullighan, C. G. / Bardy, P. G. et al. | 2007
- 128
-
353:Thymoglobulin stimulates Th2-type alloresponses and preserves regulatory T cell (Treg) function in-vitroMahmud, D. / Chunduri, S. / Maciejewski, J. J. / Iqbal, R. / Rondelli, D. et al. | 2007
- 128
-
355:Immunophenotypic and proteomic characterization of cord blood (CB) CD56bright and CD56dim NK cells: Potential role of CB CD56dim mediating GVL effectShereck, E. / Satwani, P. / van de Ven, C. / Ayello, J. / Crockett, D. / Lim, M. / Wapner, R. J. / Day, N. / Jiang, H. / Cairo, M. S. et al. | 2007
- 128
-
354:Stem cell transplantation (SCT) with and without conditioning for primary immune deficiency (PID) in children: A single center 25 year experienceRosenblatt, H. M. / Leung, K. / Myers, G. D. / Shearer, W. T. / Krance, R. C. et al. | 2007
- 129
-
356:First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) for patients with acute myeloblastic leukemia (AML) in first complete remission (CR1)Blaise, D. / Tabrizi, R. / Faucher, C. / Mohty, M. / Bay, J. O. / Boiron, J. M. / Marit, G. / Furst, S. / Charbonnier, A. / Prebet, T. et al. | 2007
- 129
-
357:The use of adjunctive leukemia specific therapy to improve outcome in patients with chronic myeloid leukemia transplanted using a reduced intensity conditioning (RIC) regimenCraddock, C. F. / Griffiths, M. J. / Arrazi, J. M. / Siddique, S. / Pallan, L. / Lennard, A. L. / Byrne, J. L. / Olavarria, E. et al. | 2007
- 130
-
359:Outcome of matched sibling donor hematopoietic stem cell transplantation for standard risk pediatric acute myelogenous leukemia in first complete remissionGassas, A. / Afzal, S. / Ishaqi, M. K. / Doyle, J. et al. | 2007
- 130
-
360:Pediatric patients with malignancies transplanted with plasma depleted cord blood (PD CB) – an audited analysis of 91 patientsGraham, M. / Chan, L. L. / Eames, G. / Tan, A. M. / Tan, P. L. / Rosenthal, J. / Nademanee, A. / Karanes, C. / Gjertson, D. / Wang, B. et al. | 2007
- 130
-
358:Outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia in third complete remission (CR3): A vital role for graft-versus-host-disease/graft-versus-leukemia effect in survivalGassas, A. / Ishaqi, M. K. / Afzal, S. / John, D. J. et al. | 2007
- 131
-
363:Adult patients with malignancies transplanted with plasma depleted cord blood (PD CB) – a retrospective audited analysis of 68 patientsNademanee, A. / Graham, M. / Ballen, K. / Tan, A. M. / Rosenthal, J. / Karanes, C. / Eames, G. / Tan, P. / Jaing, T. H. / Wang, B. et al. | 2007
- 131
-
361:Superior disease-free survival in acute myelogenous leukemia/myelodysplastic syndrome receiving reduced-intensity allogeneic hematopoietic stem cell transplantation from unrelated donors using fludarabine, busulfan, and total lymphoid irradiationKato, K. / Khaled, Y. / Braun, T. / Levine, J. E. / Ferrara, J. L. / Mineishi, S. / Gregory, Y. A. et al. | 2007
- 131
-
362:Superior EFS and reduced TRM in patients with Int-2 and High risk MDS and secondary AML after initial cytoreduction with 5-azacytidineMcCarty, J. M. / Roberts, C. H. / Candler, K. S. / Edwards, R. W. / Chung, H. M. / Shickle, L. M. et al. | 2007
- 132
-
365:BCR/ABL positivity preceding stem cell transplantation seems to be a better predictor of subsequent relapse than Ig/TCR approach in childhood Ph+ acute lymphoblastic leukemiaMuzikova, K. / Krejcikova, K. / Sedlacek, P. / Eva, F. / Jan, Z. / Jan, T. et al. | 2007
- 132
-
364:Effect on interruption of CXCR4-CXCL12 and VLA4-VCAM1 axes on mobilization and sensitization of leukemia cells and normal stem cells to chemotherapyRamirez, P. A. / Nervi, B. / Bridger, G. / Dipersio, J. F. et al. | 2007
- 133
-
367:Reduced intensity stem cell transplant (RIST) as salvage treatment for relapse following myeloablative allogeneic transplantation in adult acute myeloid leukemiaSica, R. A. / Vosganian, G. S. / Tuscano, J. M. / Law, L. Y. / Richman, C. M. et al. | 2007
- 133
-
368:Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)Sorror, M. L. / Storer, B. / Sandmaier, B. M. / Maris, M. B. / Shizuru, J. / Niederwieser, D. / Agura, E. / Chauncey, T. / Maziarz, R. / Pulsipher, M. et al. | 2007
- 133
-
366:Fludarabine and treosulfan; A novel reduced-toxicity regimen with effective anti-leukemia activity in patients with AML and MDSShimoni, A. / Hardan, I. / Shem-Tov, N. / Yerushalmi, R. / Nagler, A. et al. | 2007
- 134
-
370:Fludarabine-busulphan reduced intensity conditioning (RIC) identical sibling allogeneic stem cell transplantation (allo-SCT) in high risk acute myeloid leukemia and myelodisplastic syndromeValcarcel, D. / Martino, R. / Martin, J. / Ferra, C. / Sampol, A. / Nieto, J. B. / Carrera, D. / Pinana, J. L. / Caballero, D. / Ribera, J. M. et al. | 2007
- 134
-
369:Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemiaStein, A. / O’ / Donnell, M. / Snyder, D. / Parker, P. / Nademanee, A. / Falk, P. / Kogut, N. / Rosenthal, J. / Palmer, J. et al. | 2007
- 135
-
371:Altered gene expressions in human myeloid leukemia cells resistant to busulfanValdez, B. C. / Ramdas, L. / de Lima, M. / Jones, R. / Kornblau, S. / Murray, D. / Bethancourt, D. / Mehta, V. / Champlin, R. E. / Andersson, B. S. et al. | 2007
- 136
-
372:Educating the pediatric blood and marrow transplant patients and families with diagnoses of genetic versus malignant diagnosesAllison-Thacker, J. / Robinette, D. / Kurtzberg, J. et al. | 2007
- 136
-
374:BMT discharge nurse: The force behind the discharge processAustria-Granada, M. L. / Johnston, P. / Dela Cruz, B. / Estepa-Estrella, J. M. / Febryani, I. et al. | 2007
- 136
-
375:Hematopoietic stem cell transplantation for systemic lupus erythematosus: Unique challenges and strategies for the nursing care teamBabb, R. / Shelburne, N. / Castro, K. / Krumlauf, M. / Pavletic, S. Z. et al. | 2007
- 136
-
373:Blood and marrow transplant nursing journal club: An effective method for providing continuing nursing educationAnderson-Reitz, L. A. / Brougher, L. I. / Shaw, T. et al. | 2007
- 137
-
378:An exploratory analysis of symptom experience at days 30 and 100 following allogeneic hematopoietic stem cell transplantation (AHSCT)Bevans, M. F. / Mitchell, S. A. / Marden, S. et al. | 2007
- 137
-
377:Outcomes of pediatric patients transplanted a second time after experiencing graft failure with unrelated donor umbilical cord blood transplantationBaker, J. H. / Martin, P. L. / Driscoll, T. / Szabolcs, P. / Allison, J. / Gurganus, K. / Ciocci, G. / Parikh, S. / Prasad, V. / Kurtzberg, J. et al. | 2007
- 137
-
376:Treatment of acute graft vs. host disease after unrelated donor umbilical cord blood transplantation in pediatric patientsBaker, E. J. / Frey, M. A. / Kurtzberg, J. et al. | 2007
- 138
-
380:Nursing initiatives to address ethical dilemmas on a blood and marrow transplant (BMT) unitCauston, C. A. / Johnston, P. A. / Neumann, J. L. / Slieper, C. et al. | 2007
- 138
-
381:Prophylactic use of high concentration fluoride rinse in the hematopoietic cell transplant patient: Promising potential for decreasing oral mucositisEast, K. A. / Oholendt, M. S. / Kamble, R. / Carrum, G. / Bross, A. et al. | 2007
- 138
-
379:Fly me to the moonCaraher, R. / Ahmed, S. / Frey, M. A. / Jordan, L. E. / Kurtzberg, J. et al. | 2007
- 139
-
385:“Recovery”: development of a BMT discharge teaching pamphletGaravgalia, K. et al. | 2007
- 139
-
383:A BMT-based diabetic teaching program: Responding to the needs of allogeneic patients with steroid-induced hyperglycemiaEstepa-Estrella, J. M. / Johnston, P. / dela Cruz, B. / Austria-Granada, M. L. / Ascuna, J. et al. | 2007
- 139
-
384:A culture of safety: Promoting a safe environment on the duke pediatric blood and marrow transplant unitFrey, M. A. / Hutchinson, B. et al. | 2007
- 139
-
382:Making the leap: Successful integration of a pediatric bone marrow transplant population within an existing adult bone marrow transplant unitEron, B. / Marlow, C. / Coghill, A. / Talbert, G. / Shea, T. et al. | 2007
- 140
-
386:Development of a pediatric HPC donor history questionnaire (DHQ)Halverson, T. L. et al. | 2007
- 140
-
387:A reimmunization program for pediatric hematopoietic progenitor cell transplant (HPCT) recipientsKlinger, E. F. / Daum, C. D. et al. | 2007
- 140
-
388:The development of a comprehensive quality management plan in the blood and marrow stem cell transplant settingKurosky, A. S. / DiBiase, R. / Carolin, K. et al. | 2007
- 141
-
391:Health, performance and psychosocial adjustment of haematopoietic stem cell transplantation in teenagersLee, J. H. / Kim, K. S. / Choi, S. E. / Bok, G. N. / Lee, S. Y. et al. | 2007
- 141
-
390:An explorative qualitative pilot study of how parents and children experience the treatment with allogeneic stem cell transplantaiton (SCT) focusing on improvement of nursing careLaursen, H. B. / Heilman, C. et al. | 2007
- 141
-
389:Annual blood and marrow transplant patient celebratrion ignites hope, strength and recoveryLaub, L. M. et al. | 2007
- 142
-
392:Fundamental nursing responsibilities in mesenchymal stem cell infusionMaldonado, M. / Kebriaei, P. / Granada, M. L. / Szewczyk, N. et al. | 2007
- 142
-
393:The role of immunoglobulin in hematopoietic stem cell transplantationMartin, A. / Neumann, J. et al. | 2007
- 142
-
394:More than my marrow: Development and implementation of a hematopoietic stem cell donor recognition programMcMullin, B. / Sorensen, S. / Choroszy, M. / Carstens, K. et al. | 2007
- 143
-
395:Heart success with blood & marrow transplant patients: A multidisciplinary approach for congestive heart failure patientsMeyers, A. L. / Trueman, A. / Johnston, P. / Woods, M. / Fadol, A. / Oliver, T. / Martin, A. et al. | 2007
- 143
-
397:Use of N-acetylcysteine for hepatic veno-occlusive disease prophylaxis in pediatric hematopoietic stem cell transplant patientsEnglert, L. / Murphy, P. / Quinn, M. / Tat, C. et al. | 2007
- 143
-
396:Nursing care of the child receiving inhaled ribavirin for the treatment of RSV in the peritransplant periodMurphy, C. / Frey, M. / Kurtzberg, J. et al. | 2007
- 144
-
400:Reducing central venous catheter related bloodstream infections in children with cancerNorville, R. / Horvath, B. / Lee, D. / Hyde, A. / Gregurich, M. A. / Hilburn, J. / Versalovic, J. / Mueller, B. / Stark, J. / Hockenberry, M. et al. | 2007
- 144
-
399:Choice of diet as part of treatment for GI GVHDNiangar, G. A. et al. | 2007
- 144
-
401:Stem cell transplantation for osteopetrosis: One center’s experienceO’ / Connor, M. P. / Myers, K. / Melone, M. / Lehmann, L. et al. | 2007
- 144
-
398:Longitudinal assessment of quality of life and symptoms of ethnically diverse blood and marrow transplantation patientsNeumann, J. L. / Cohen, M. Z. / Mendoza, T. / Giralt, S. / Cleeland, C. et al. | 2007
- 145
-
402:Cardiac amyloidosis and stem cell transplantation: What nurses need to knowOliver, T. D. et al. | 2007
- 145
-
Umbilical Cord Blood Produces Small Megakaryocytes After TransplantationIgnatz, M. / Sola-Visner, M. / Rimsza, L. M. / Fuchs, D. / Shuster, J. J. / Li, X. M. / Jotwani, A. / Staba, S. / Wingard, J. R. / Hu, Z. et al. | 2007
- 145
-
404:Surveillance, evaluation and management of passenger lymphocyte syndromeRice, J. M. / Sirilla, J. A. / Krugh, D. W. / Crawford, R. / Benson, D. M. / Devine, S. M. et al. | 2007
- 145
-
403:Primary care in a tertiary setting of stem cell transplantationRhodes, B. A. et al. | 2007
- 146
-
407:Predictive factors for engraftment in bone marrow transplant recipientsRivera, Z. P. / Gulbis, A. M. / de Lima, M. / Rondon, G. et al. | 2007
- 146
-
406:Clinical practice review: Utilizing evidenced-based practice to develop standards of care for the immune-suppressed blood and marrow transplant (BMT) patient across care settingsRimkus, C. F. / O’ / Neill, S. / Hendricks, D. / Laub, L. et al. | 2007
- 146
-
408:Development of a “liver biopsy and management plan of care” for hematopoietic stem cell transplant patientsSirilla, J. A. / Krugh, D. / Ohr, M. / Devine, S. M. et al. | 2007
- 146
-
405:Breaking up the monotony: Protocol specific patient education pathwaysRimkus, C. F. et al. | 2007
- 147
-
410:Gatifloxacin as a possible cause of hypoglycemia in a non-diabetic stem cell transplant patientSmith, V. P. / Gulbis, A. M. / Sorensen, S. et al. | 2007
- 147
-
411:Flex time: An opportunity for employee satisfaction in the transplant coordinator teamStary, S. J. / Koval, E. et al. | 2007
- 147
-
409:Sibling support program: Model for multidisciplinary intervention initiated by nursingSkeens, M. A. / Canner, J. / Garee, A. M. / Young-Saleme, T. / Termuhlen, A. et al. | 2007
- 147
-
412:PEG-filigrastim post-chemotherapy to mobilise PBSC in paediatric oncology patientsStephen, K. P. / Montgomery, K. V. / Shaw, P. J. / Antonenas, V. et al. | 2007
- 148
-
413:The duke pediatric blood and marrow transplant nursing graduate integration programStewart, R. M. / Frey, M. A. / Stanton, T. / Guess, C. / Kurtzberg, J. et al. | 2007
- 148
-
414:Engraftment syndrome: A complication of hematopoietic stem cell transplantationSummers, E. / Frey, M. A. / Kurtzberg, J. et al. | 2007
- 148
-
415:Development of a multidisciplinary prospective study to evaluate the prevalence of BK virus in hemorrhagic cystitis (HC) patients in unrelated donor hematopoietic stem cell transplantation (UD HSCT) recipientsSzewczyk, N. A. / Gilman, L. A. / Neumann, J. / Gulbis, A. / Walker, J. A. / Patah, P. A. / Petropoulos, D. / El-Zimaity, M. / Anderlini, P. / Tarrand, J. et al. | 2007
- 149
-
416:Do we know the educational needs of nurses working with physicians who refer patients to transplant centers?Tierney, D. K. / Schmit-Pokorny, K. / Sorensen, S. / McDermott, K. / Devine, H. et al. | 2007
- 149
-
418:Analysis of outcomes for vascath insertion for paediatric peripheral blood stem cell collection: A queensland experienceShergold, J. / Travers, R. / Shelley, R. et al. | 2007
- 149
-
419:Establishment of a long-term allogeneic blood and marrow program for early detection of complication and measuring outcomesTrevino, C. M. / Neumann, J. / Couriel, D. / Popat, U. / Hsu, Y. et al. | 2007
- 149
-
417:Hematopoietic stem cell transplant nursing: Competency-based trainingRodriguez, A. L. / Tokarz-Vancura, L. et al. | 2007
- 150
-
420:BK virus: A problem in the pediatric bone marrow transplant patientVan Stelle, J. L. / Sickel, A. D. / Hild, E. / Kissane, R. / Bathurst, J. / Quinones, R. / Giller, R. H. / Peltz, A. C. / Christensen, M. J. / Adams, J. et al. | 2007
- 150
-
421:Improving yield from blood cultures for transplant patientsWood, J. M. / Eilers, J. / DeVetten, M. / Freifeld, A. et al. | 2007
- 150
-
422:The safety and efficacy of prophylactic voriconazole to prevent fungal infections in pediatric blood and marrow transplant patientsZbylut, C. A. / Frey, M. A. / Kurtzburg, J. et al. | 2007
- 150
-
423:Prophylaxis of pneumocystis carinii pneumonia (PCP) with inhaled pentamidine in pediatric patients undergoing hematopoietic stem cell transplantationZelko, V. S. / Frey, M. A. / Kurtzberg, J. et al. | 2007
- 151
-
Promiscuity of the AlloHLA-A2 Restricted T Cell Repertoire Hampers the Generation of Minor Histocompatibility Antigen-specific Cytotoxic T Cells across HLA BarriersOosten, L. E. / Blokland, E. / Kester, M. G. / Falkenburg, J. H. / van Halteren, A. G. / Goulmy, E. et al. | 2007
- 152
-
426:Use of low dose rasburicase in the management of hyperuricemia in tumor lysis syndromeJin, R. / Shayani, S. / Htoy, S. / Fujinami, W. et al. | 2007
- 152
-
427:Triazole-resistant Candida glabrata oral candidiasis and associated gastrointestinal syndrome in allogeneic hematopoietic cell transplant: Successful treatment with oral amphotericin BOholendt, M. S. / Darcourt, J. / Kamble, R. / Carrum, G. et al. | 2007
- 152
-
425:A double blinded pilot study of aprepitant vs placebo combined with standard antiemetics for the control of nausea and vomiting during hematopoietic cell transplantationBubalo, J. S. / Leis, J. F. / Curtin, P. T. / Kovascovics, T. J. / Meyers, G. / Hayes-Lattin, B. / Jones, N. / McCune, J. S. / Munar, M. Y. et al. | 2007
- 152
-
424:Beam autograft in a dialysis patient: A case reportBooth, D. et al. | 2007
- 153
-
428:Palonosetron for the prevention of acute and delayed nausea and vomiting following high dose melphalan and autologous stem cell transplantationTrifilio, S. / Pi, J. / Fishman, M. / Masino, K. / Kaniecki, K. / Mehta, J. et al. | 2007
- 153
-
429:Voriconazole prophylaxis in patients at high risk for invasive fungal infections following allogeneic hematapoetic stem cell transplantionTrifilio, S. / Singhal, S. / Williams, S. / Winter, J. / Tallman, M. / Gordon, L. / Evens, A. / Frankfurt, O. / Pi, J. / Mehta, J. et al. | 2007
- 154
-
430:Discordance between voriconazole dose and plasma concentrations: Implications for therapeutic blood monitoringTrifilio, S. / Kamal, K. / Pennick, G. / Pi, J. / Golf, M. / Mehta, J. et al. | 2007
- 155
-
Clinical Research Associate—Data Management| 2007
- 155
-
431:Development of a Health Insurance Portability and Accountability Act (HIPAA) compliant customized electronic summary face sheet for coordination of care and data management needs available pre-hospital admission for each blood and marrow transplant (BMT) patientMacchio, D. M. / Dubel, K. A. / Lipka, P. E. / Rieman, C. M. / Hernandez, L. K. / Cashaw, A. C. / Bouquard, A. J. / Werder, M. J. / Smiley, S. I. / Padmanabhan, S. et al. | 2007
- 164
-
CD154 Blockade and Donor-Specific Transfusions in DLA-Identical Marrow Transplantation in Dogs Conditioned with 1-Gy Total Body IrradiationJochum, C. / Beste, M. / Zellmer, E. / Graves, S. S. / Storb, R. et al. | 2007
- 172
-
Reticulocyte Maturation Parameters Are Reliable Early Predictors of Hematopoietic Engraftment after Allogeneic Stem Cell TransplantationMolina, J. R. / Sanchez-Garcia, J. / Torres, A. / Alvarez, M. A. / Serrano, J. / Casañ / o, J. / Gomez, P. / Martinez, F. / Rodriguez, A. et al. | 2007
- 183
-
High-dose Therapy with Single Autologous Transplantation versus Chemotherapy for Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled TrialsKoreth, J. / Cutler, C. S. / Djulbegovic, B. / Behl, R. / Schlossman, R. L. / Munshi, N. C. / Richardson, P. G. / Anderson, K. C. / Soiffer, R. J. / Alyea, E. P. et al. | 2007
- 197
-
Detrimental Effect of Natural Killer Cell Alloreactivity in T-replete Hematopoietic Cell Transplantation (HCT) for Leukemia PatientsSun, J. Y. / Dagis, A. / Gaidulis, L. / Miller, M. M. / Rodriguez, R. / Parker, P. / Nademanee, A. / Falk, P. / Rosenthal, J. / Forman, S. J. et al. | 2007
- 206
-
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell TransplantationTay, J. / Tinmouth, A. / Fergusson, D. / Huebsch, L. / Allan, D. S. et al. | 2007
- 218
-
Allogeneic Bone Marrow Transplantation in First Remission for Children with Ultra-high-risk Features of Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study ReportSatwani, P. / Sather, H. / Ozkaynak, F. / Heerema, N. A. / Schultz, K. R. / Sanders, J. / Kersey, J. / Davenport, V. / Trigg, M. / Cairo, M. S. et al. | 2007
- 228
-
Higher Numbers of Blood CD14+ Cells before Starting Conditioning Regimen Correlate with Greater Risk of Acute Graft-versus-Host Disease in Allogeneic Stem Cell Transplantation from Related DonorsArpinati, M. / Chirumbolo, G. / Saunthararajah, Y. / Stanzani, M. / Bonifazi, F. / Bandini, G. / Baccarani, M. / Rondelli, D. et al. | 2007
- 235
-
Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course Methotrexate Followed by Unmodified HLA-Matched Related or Unrelated Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Hematologic MalignanciesSmall, T. N. / Young, J. W. / Castro-Malaspina, H. / Prockop, S. / Wilton, A. / Heller, G. / Boulad, F. / Chiu, M. / Hsu, K. / Jakubowski, A. et al. | 2007
- 245
-
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination ModelBaker, J. N. / Barfield, R. / Hinds, P. S. / Kane, J. R. et al. | 2007
- 255
-
Prospective Clinical Trials in BMT Come of Age in the US: The Blood and Marrow Transplant Clinical Trials NetworkKeating, A. et al. | 2007
- 257
-
Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered QuestionsWeisdorf, D. / Carter, S. / Confer, D. / Ferrara, J. / Horowitz, M. et al. | 2007
- 263
-
Hematopoietic Progenitor Cell Transplantation in 2007: New Challenges and New Opportunities for the Center for International Blood and Marrow Transplant ResearchGiralt, S. et al. | 2007
- 265
-
T-Cell Receptor Vα Usage by Effector CD4+Vβ11+ T Cells Mediating Graft-versus-Host Disease Directed to Minor Histocompatibility AntigensDiRienzo, C. G. / Murphy, G. F. / Friedman, T. M. / Korngold, R. et al. | 2007
- 277
-
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor VaccineJing, W. / Orentas, R. J. / Johnson, B. D. et al. | 2007
- 293
-
Survival and Function of MiHA Epitope-Specific Host CD8 TM Cells Following Ablative Conditioning and HCTShatry, A. M. / Roopenian, D. C. / Levy, R. B. et al. | 2007
- 299
-
Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair AnalysisRussell, J. A. / Turner, A. R. / Larratt, L. / Chaudhry, A. / Morris, D. / Brown, C. / Quinlan, D. / Stewart, D. et al. | 2007
- 307
-
Pharmacokinetic Disposition and Clinical Outcomes in Infants and Children Receiving Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell TransplantationSchechter, T. / Finkelstein, Y. / Doyle, J. / Verjee, Z. / Moretti, M. / Koren, G. / Dupuis, L. L. et al. | 2007
- 315
-
Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated DonorMorishima, Y. / Yabe, T. / Matsuo, K. / Kashiwase, K. / Inoko, H. / Saji, H. / Yamamoto, K. / Maruya, E. / Akatsuka, Y. / Onizuka, M. et al. | 2007
- 329
-
Safe and Efficacious Allogeneic Bone Marrow Transplantation for Nonmalignant Disorders Using Partial T Cell Depletion and No Posttransplantation Graft-Versus-Host-Disease ProphylaxisElhasid, R. / Arush, M. B. / Zaidman, I. / Leiba, R. / Barak, A. B. / Postovsky, S. / Haddad, N. / Katz, T. / Pollack, S. / Sami, I. et al. | 2007
- 339
-
Efficacy of CD34+ Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation after Total Body IrradiationSingh, A. K. / Savani, B. N. / Albert, P. S. / Barrett, A. J. et al. | 2007
- 345
-
Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage DysplasiaScott, B. L. / Storer, B. E. / Greene, J. E. / Hackman, R. C. / Appelbaum, F. R. / Deeg, H. J. et al. | 2007
- 355
-
Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential ThrombocythemiaKerbauy, D. M. / Gooley, T. A. / Sale, G. E. / Flowers, M. E. / Doney, K. C. / Georges, G. E. / Greene, J. E. / Linenberger, M. / Petersdorf, E. / Sandmaier, B. M. et al. | 2007
- 366
-
Fludarabine, Cyclophosphamide, and Antithymocyte Globulin for a Patient with Dyskeratosis Congenita and Severe Bone Marrow FailureOstronoff, F. / Ostronoff, M. / Calixto, R. / Florê / ncio, R. / Domingues, M. C. / Souto Maior, A. P. / Sucupira, A. / Tagliari, C. et al. | 2007
- 369
-
Sympathectomy Protects Denervated Skin from Graft-Versus-Host DiseaseKharfan-Dabaja, M. A. / Anasetti, C. / Ferrara, J. L. et al. | 2007